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11 Recurrent  metastatic  melanoma  provides  a  unique  opportunity  to  analyze  disease  evolution  in 
12 
13 
metastatic cancer. Here, we followed 8 patients with an unusually prolonged history of metastatic 
14 
15 
16 melanoma, who developed a total of 26 recurrences over several years. Cell lines derived from each 
17 
18 metastasis were analyzed by comparative genomic hybridization and global transcript analysis. We 
19 
20 observed   that   conserved,   patient-specific   characteristics   remain   stable   in   recurrent   metastatic 
21 
22 
23 melanoma even after years and several recurrences. Differences among individual patients exceeded 
24 
25 within-patient lesion variability, both at the DNA copy number (p<0.001) and RNA gene expression level 
26 




c-kit  proto-oncogene  throughout  multiple  recurrences.  Interestingly,  subsequent  recurrences  of 
31 
32 different patients did not display consistent or convergent changes toward a more aggressive disease 
33 
34 phenotype. Finally, sequential recurrences of the same patient did not descend progressively from each 
35 
36 other, as irreversible mutations, such as homozygous deletions were frequently not inherited from 
37 
38 
39 previous  metastases.  This  study  suggests  that  the  late  evolution  of  metastatic  melanoma,  which 
40 
41 dramatically turns an indolent disease into a lethal phase, is prone to preserve case-specific traits over 
42 
43 multiple recurrences and occurs through a series of random events that do not follow a consistent step- 
44 
45 














metastatic phase that progresses slowly, to a rapid evolution in the declining phase of one patient’s life. 
Studying  longitudinally  several  recurrent  melanoma  metastases  of  a  rare  collection  of  eight 
individuals who developed multiple recurrences over a period of years (see Table S1), we sought a 

















10 Cancer progression is usually studied cross-sectionally, comparing lesions obtained from different 
11 
12 
13 patients, excised at various stages. By combining these snapshots, the natural history of the disease can 
14 
15 be indirectly reconstructed. In contrast, the preferable longitudinal analysis of sequential lesions in the 
16 
17 same patients is usually not feasible, especially difficult to perform in rapidly progressing cancers, such 
18 
19 
as melanoma, and particularly challenging when analyzing disease progression in metastases (Bonsing et 
21 
22 al, 1993; Kuukasjarvi et al, 1997; Navin et al, 2011). 
23 
24 However, the limited number of such longitudinal studies leaves several questions open. First, cross- 
25 
26 sectional studies do not allow an estimate of the extent in which patient-specific traits remain stable 
27 
28 
29 over time. Therefore, it is difficult to assess the stability of such patient-specific traits over time, which is 
30 
31 a question of basic importance in personalized cancer therapy (Gupta et al, 2009; Harbst et al, 2010; 
32 
33 Navin et al, 2010). 
34 
35 
36 In addition, with cross-sectional analyses it is impossible to test, whether late disease development 
37 
38 follows a pattern of sequential somatic microevolution, or subsequent metastases represent individual 
39 
40 buddings from a stable set of cancer progenitors creating independently established new metastatic 
41 
42 
lesions (Sabatino et al, 2008; Wang et al, 2006). 
44 
45 Finally, it is difficult to quantify whether sequential steps are involved in late stage progression, and 
46 













expression (GX) data is present, but limited in advanced cancer (Bacolod and Barany, 2010; Sabatino et 
al, 2008; Spivey et al, 2012). Among 4,340 genes eligible for analysis, 2,766 correlated weakly (Pearson’s 
correlation R<0.3, p<0.05, false discovery rate (FDR) 0.05) and 272 strongly (R<0.5, p<0.05, FDR 0.01) in 









3 of a single case (Sabatino et al, 2008; Wang et al, 2006) focusing on traits remaining stable and changes 
4 
5 
6 repeated consistently among multiple developing recurrent metastases of several melanoma patients. 
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25 Since the cases with multiple recurrent metastases studied here differ behaviorally from classic 
26 
27 
metastatic melanoma due to their unusually protracted course, we first evaluated whether the cell lines 
29 




34 Array comparative genomic hybridization (aCGH) confirmed that the chromosomal distribution 
35 
36 
37 of  copy  number  (CN)  alterations  (CNAs)  prominently  observed  here  are  in  line  with  previous 
38 
39 observations (Fig. 1a) (Jonsson et al, 2007; Roschke et al, 2003; Spivey et al, 2012; Thompson et al, 
40 
41 1995). Also, at the individual gene level, most genes were affected by copy number gains and losses in 
42 
43 
44 accordance with others’ reports (Grafstrom et al, 2005; Jonsson et al, 2007; Okamoto et al, 1999; Pirker 
45 
46 et al, 2003; Shi et al, 2012) (Fig. 1b, see full data set in Table S2). 
47 






















3 Taken  together,  this  dataset  was  representative  of  typical  characteristics  of  metastatic 
4 
5 
6 melanoma genomics, as reported in the literature (Bacolod and Barany, 2010; Jonsson et al, 2007; 
7 









17 Following a rare case of metastatic melanoma that recurred several times over a decade, we 
18 
19 
previously observed that in spite of the stochastic and selective forces affecting its genome, stable 
21 
22 characteristics prevailed to the point that recurrent lesions derived from this patient clustered away 
23 
24 from heterologous randomly collected cases (Sabatino et al, 2008; Wang et al, 2006). This patient- 
25 
26 specific stability, if shared by other cases of advanced melanoma, could have fundamental implications 
27 
28 
29 for personalized cancer therapy. Thus, in this study, we first analyzed whether the previous observations 
30 
31 could be generalized to a larger set of patients. 
32 
33 First we compared CNA and GX patterns on a global genomic scale among cell lines from the 
34 
35 
36 eight  patients  with  multiple  recurrences. Multidimensional  scaling  (MDS),  a computational method 
37 
38 enabling visualization of sample relatedness within large scale genetic data demonstrated that even 
39 
40 after years, recurrent metastases of a given patient remained closely related, keeping clear distance 
41 
42 
from others’ metastases (Fig. 2a and 2c). By comparing all metastases in all possible pairs (325 pairs 
44 
45 total), we found that MDS distances between subsequent metastases (estimates of sample relatedness) 
46 
47 of the same patient were significantly shorter than those between metastases of different patients (Fig. 
48 












melanoma cell biology are expressed stably within a given patient, and may, in turn, be responsible for 










3 We next searched for genomic aberrations typically specific to a given patient. We found that 
4 
5 
6 stable case-specific CNAs occurred in chromosomes 1, 5, 13, and 19 (Fig. 3a One Way Analysis of 
7 
8 variance (ANOVA), p<0.05, FDR<0.001, see Table S3 for details). Similarly, 925 genes were found to have 
9 
10 stable, patient-specific expression; 61 among them could be categorized functionally as melanoma- 
11 
12 
13 related by the Ingenuity Pathway Analysis database (Fig. 3b, One-Way ANOVA, p<0.05, FDR<0.05). The 
14 
15 latter included several genes with known tumorigenic properties supporting autonomous proliferation 
16 
17 (KIT, MYC, CDK2, RBL2), controlling genomic stability (BRCA1), apoptosis and cell survival (TP53BP2, 
18 
19 
CASP8, TEP1), adhesion and motility (CDH1, ITGA4), invasiveness, matrix remodeling (MMP15, MMP19), 
21 
22 angiogenesis   (ANGPT1,   EGF),   modulation   of   anti-tumor   immunity,   (large   clusters   of   major 
23 
24 histocompatibility complex   class I and II transcripts, the latter correlating with CIITA expression) and 
25 
26 several melanoma antigens (MAGE-A1, -A4, -A9, -B2, -C2). This observation suggests that genes highly 
27 
28 
29 relevant to melanoma progression retain stable patient-specific expression levels over long periods of 
30 
31 time (Fig. 3b). 
32 
33 Notably among all possible patient-to-patient comparisons (28 pairwise comparisons involving 8 
34 
35 
36 patients), 37 genes demonstrated patient-specific expression pattern with significant differences among 
37 
38 patients and an at least two-fold change in >70% of all pair wise comparisons. These included MAGE-A4, 
39 
40 -B2, -C2, BAGE-2, and KIT (see Table S4). To further test these results, we analyzed KIT protein levels by 
41 
42 
flow cytometry in the investigated cell lines. Our analysis disclosed that although KIT expression is 
44 
45 frequently affected by post-transcriptional regulation, KIT protein levels remain consistent throughout 
46 
47 multiple recurrences of individual patients, and whenever expressed, correlate well with mRNA data 
48 












fatal lesion in a given patient might be different from earlier ones, we compared the latter with the 
former (p<0.05 FDR 0.05), again without observing consistent differences. Taken together, no consistent 















8 Next, we asked whether subsequent metastases from different patients progressively converge 
9 
10 to reach a terminal, potentially lethal “hyper-aggressive” status. This would imply that on average, early 
11 
12 
13 (e.g. first) metastases of individual patients would be more different, more distant from each other than 
14 
15 late (e.g. the last) metastases of the same individuals. MDS genomic distances demonstrate that this is 
16 
17 not the case (Fig. 4a and 4b), neither at the CN or at the GX level. 
18 
19 
To corroborate this finding, we next attempted to identify consistent CN or GX changes that 
21 
22 might represent a recurrent theme in the transition from earlier to later metastases in a given patient. 
23 
24 However,  statistical  analysis  was  unable  to  identify  changes  in  CN  alterations  or  GX  patterns  that 
25 
26 constitute consistent trends in subsequent recurrences of metastatic melanoma, (Two-Way RM ANOVA 
27 
28 
29 p<0.05 FDR 0.05). First, an analysis of all recurrent metastases inclusive of patient identity and lesion 
30 
31 sequence revealed no consistent changes between subsequent metastases. Next, since patients with 
32 
33 large numbers of recurrences dominate the analysis in such a pair wise comparison, we decreased or 
34 
35 
36 eliminated differences in per-patient sample sizes. To this end, we first replaced multiple synchronous 
37 
38 metastases  with  a  single  averaged  value  for  each  parameter  tested  (p<0.05  FDR  0.05).  Also,  in  a 
39 
40 separate analysis we limited the evaluated cases to 3 randomly selected samples per patient (p<0.05 
41 
42 
FDR 0.05). No consistent changes were found by either analysis. Next, assuming that the first and last 
44 
45 available lesions in a given patient were most distant genetically, we restricted the analysis to these 
46 
47 extreme pairs; but again, a pair wise analysis including patient identity failed to identify statistically 
48 












NRAS wild type throughout (not shown). Next we analyzed the fate of homozygous deletions (-/-) that 










3 number  or  RNA  gene  expression  level,  regardless  of  the  approach  used  for  sample  selection  and 
4 
5 
6 grouping before statistical analysis. 
7 
8 In line with this observation, comparison of the first metastasis from a given patient with his 
9 
10 subsequent ones demonstrated that the latter are not necessarily drifting progressively further from the 
11 
12 




17 We also tested whether multiple cycles of phenotype switching between proposed invasive and 
18 
19 
proliferative phenotypes (Hoek et al, 2008) could explain a seemingly stochastic drifting of recurrent 
21 
22 melanoma metastases. We found that this model may provide partial explanation for our observations, 
23 
24 as key genes of the two phenotypes were expressed in an alternating fashion, and the two phenotypes 
25 
26 seemed to change frequently back and forth through the recurrences of most (e.g. patients B, C, D, F, G), 
27 
28 









38 Since no step-wise evolutionary pattern could be discerned, we next asked whether recurrent 
39 
40 metastases from the same patient descend sequentially from one another, i.e. if they acquire new 
41 
42 
mutations in a cumulative fashion. To this end, we followed the fate of common BRAF, NRAS mutations 
44 
45 (Colombino   et  al,  2012)  and  homozygous  deletions  (-/-)  in  subsequent  recurrent  metastases. 
46 
47 Unfortunately,  BRAF  and  NRAS  status  turned  out  to  be  uninformative  in  this  regard,  because  as 
48 












This study analyzes a specific time point in the natural history of cancer when advanced disease 










3 have been described. Based on this, we assumed that if subsequent recurrent metastases of the same 
4 
5 
6 patient show reversions of homozygous deletions, they cannot sequentially descend from each other. 
7 
8 A  total  of  33  contiguous homozygous  deletions  were  found  affecting  the  CDKN2A/CDKN2B 
9 
10 region, various interferon genes, B2M, major histocompatibility complex genes, etc. Out of these, 25 
11 
12 
13 deletions were eligible for analysis as they emerged in a metastasis for which there was at least a 
14 
15 subsequent metastasis to evaluate (Fig. 5b). Out of 25 eligible homozygous deletions, 15 (60%) appeared 
16 
17 to  be  reverted  in  a  given  patient’s  disease  history,  suggesting  that  in  subsequent  metastases  of 
18 
19 
recurrent melanoma, new mutations are not acquired in a cumulative fashion, and hence, recurrent 
21 









31 In initial MDS analyses, cancer cells from patients with recurrent long term metastatic disease 
32 
33 were  hardly  discernible  from  those  from  sporadically  excised,  melanoma  cases  (Fig.  2a  and  2c). 
34 
35 
36 Nevertheless, we identified a set of 177 genes differentially expressed between the two phenotypes, 
37 
38 which is a very small number compared to patient-to-patient differences, 8 of which were melanoma- 
39 
40 related.  Interestingly,  these  genes  hint  to  slower  tumor  growth  (retained  CDKN1A  and  ANAPC 
41 
42 
expression), higher sensitivity to immune- or therapy-mediated eradication (higher FAS but lower levels 
44 
















progenitor  entity.  Moreover, there was no sign of a convergent evolution in advanced late stage 










3 melanoma cell lines derived from sequentially excised metastases in unusual cases when the metastatic 
4 
5 
6 process followed a protracted course. Although the use of cell lines has significant limitations, we 
7 
8 observed that early passage cell lines maintain stable genetic traits in vitro that relate to the in vivo 
9 
10 phenotype of parental tumors (Spivey et al, 2012). Nevertheless, our samples clearly do not equal whole 
11 
12 
13 tumors, and these cases may have represented a special subset of melanoma, as well. First, these 
14 
15 recurrent melanomas displayed CDK2NA, PTEN, and BRAF copy number aberrations more frequently 
16 
17 than average cases (Hodis et al, 2012; Krauthammer et al, 2012). In addition, all 26 metastases of the 
18 
19 
analyzed 8 patients carried BRAFV600E, but displayed wild type NRAS. Conservation of BRAF mutation 
21 
22 status across metastases is in line with others’ observations (Niessner et al, 2013). However, this 
23 
24 particular BRAF/NRAS pattern is typical for melanomas arising in intermittently sun-exposed areas 
25 
26 (Colombino et al, 2012), affects cell proliferation rate (Liu et al, 2007), prognosis (Long et al, 2011), 
27 
28 
29 treatment of choice, and in this latter context, also BRAF copy numbers (Shi et al, 2012). 
30 
31 Keeping these limitations in mind, our data suggest that key elements of the framework of 
32 
33 recurrent metastatic melanomas remain stable with time; since such stability was observed in 8 out of 8 
34 
35 
36 patients,  it  possibly  represents  the  rule  rather  than  the  exception.  This  is  a  remarkable  finding 
37 
38 considering  that  at  the  same  time,  our  data  also  support  the  accepted  view  of  late  stage  cancer 
39 
40 evolution being a highly dynamic process, also shown recently by others (Gerlinger et al, 2012; Shah et 
41 
42 
al, 2012) using indirect computational inference; however, this study uniquely provides direct evidence 
44 
45 by studying serially asynchronous metastases over a long period. 
46 
47 Our findings suggest that individuality is maintained throughout a non-directional drift that does 
48 


















3 seem to be each other’s clonal descendants, or accumulate incremental changes, which is in line with 
4 
5 
6 others’ recently published observations (Colombino et al, 2012). 
7 
8 On the other hand, the observation that stable expression of cancer/testis antigens and the c-kit 
9 
10 proto-oncogene across multiple recurrences of melanoma implies that,  late stage melanoma is capable 
11 
12 
13 of displaying stable, case-specific differences directly affecting markers determining vulnerability to 
14 
15 novel forms of immunological or small molecule biotherapy (Guo et al, 2011; Tyagi et al, 2005; Tyagi and 
16 
17 Mirakhur, 2009). 
18 
19 
It remains to be clarified to what extent these observations are attributable to the effects of 
21 
22 clonal heterogeneity (Gerlinger et al, 2012; Shah et al, 2012), circulating tumor cells (Maheswaran et al, 
23 
24 2008; Yu et al, 2011) that may remain dormant for years and reset the evolutionary clock upon their 
25 
26 reactivation,  multiple  events  of  phenotype  switching  (Eichhoff  et  al,  2010;  Hoek  et  al,  2008),  or 
27 
28 
29 persistent cancer stem cells opening multiple alternative ways to cancer evolution with each individual 
30 
31 recurrence (La Porta, 2012; Shakhova and Sommer, 2012). Larger and more comprehensive studies 
32 
33 involving genome-wide DNA sequencing, epigenetic and proteomic analyses, analyzing patients with 
34 
35 
36 average survival times, and resected whole tumors instead of cell lines, are strongly warranted to clarify 
37 
























Total  genomic  DNA  of  cell  lines  was  isolated  using  the  QuickGene  DNA  whole  blood  kit  S  and  a 









3 Twenty-six  recurrent  melanoma  metastases  were  surgically  isolated  from  8  patients  experiencing 
4 
5 
6 relapse  after  one  or  more  successful  treatment  intervention(s)  with  no  signs  of  residual  disease. 
7 
8 Recurrent metastases from different tissues appeared in periods spanning 10-148 months with 8-101 
9 
10 months between recurrences (see Table S1 for all data regarding samples, patients, treatments and 
11 
12 
13 disease history). Patients received therapy and underwent surgery at the Surgery Branch of the National 
14 
15 Cancer Institute, National Institutes of Health, USA, or at the Centro di Riferimento Oncologico (Italian 
16 
17 National Cancer Institute) in Aviano, Italy. Patients were treated and samples obtained after signing 
18 
19 
informed consent, with the approval of each institute’s review board, and in accordance with the 
21 
22 Declaration of Helsinki Principles. From all lesions, stable cell cultures were established and maintained 
23 
24 at the Department of Transfusion Medicine, Clinical Center, National Institutes of Health for at least 
25 
26 eight passages. Patients experiencing recurrent metastases were labeled with capital letters; “A”, “B”, 
27 
28 
29 “C”, etc., their subsequent metastases as “A/1”, “A/2”, “B/1”, “B/2”, etc., while synchronous metastases 
30 
31 in a given patient   were labeled as “A/1a”, “A/1b” etc. All recurrent melanoma metastases analyzed 
32 
33 appeared after a single primary tumor. Another 22 melanoma cell lines isolated and maintained as 
34 
35 
36 above  were  expanded  from  melanoma  patients  with  rapid  disease  course,  for  whom  only  one 
37 
38 metastasis was available. As no extended follow up was possible in these cases, the cell lines are 
39 






















All aCGH studies were performed using Agilent’s oligo aCGH platform. Briefly, 1 µg of genomic DNA per 




















13 To exclude accidental cross-contamination of samples, low resolution HLA-typing was performed at the 
14 
15 HLA  Laboratory,  Laboratory  Services  Section,  Department  of  Transfusion  Medicine,  Clinical  Center, 
16 
17 













30 PCR was performed from 50 ng genomic DNA using the HotStarTaq Master Mix Kit (Qiagen, Valencia, 
31 
32 CA) and the following primers: BRAF exon 15 forward: 5’-TCATAATGCTTGCTCTGATAGGA-3’ BRAF exon 
33 
34 
35 15 reverse: 5’-GGCCAAAAATTTAATCAGTGGA-3’, NRAS exon 2 forward: 5’-ATAGCATTGCATTCCCTGTG-3’ 
36 
37 NRAS exon 2 reverse: 5’-CACAAAGATCATCCTTTCAGAGA-3’. PCR products were labeled using a Big Dye 
38 
39 terminator kit v3.1 (Life Technologies, Carlsbad, CA). Sequencing was performed using a 3730 Genetic 
40 
41 



















Microarray data analysis 
15 
 





3 help of an Oligo aCGH Hybridization Kit, and hybridized to 105K Human Genome CGH 105A Oligo 
4 
5 
6 Microarrays. Arrays were washed with Oligo aCGH Wash Buffers and scanned in a High-Resolution 
7 
8 Microarray Scanner (all from Agilent, Santa Clara, CA). Data were deposited in the GEO public database 
9 



























For expression array studies, the Affymetrix Gene Array System was utilized. Briefly, 250 ng total RNA 
37 
38 per sample was amplified using a WT expression kit. Next, cDNA was labeled with help of a GeneChip 
39 
40 WT Terminal Label and Control Reactions kit. Samples were then prepared for hybridization using the 
41 
42 
GeneChip Hyb Wash and Stain Kit and loaded to Human Gene ST 1.0 Arrays. Arrays were washed, PE- 
43 
44 
45 labeled  on  a  GeneChip  Fluidics  Station  450,  and  loaded  into  a  GeneChip  Scanner  3000  7G  with 
46 
47 autoloader for scanning (all from Affymetrix, Santa Clara, CA). Data were submitted to GEO and made 
48 

























Agilent aCGH microarray data were imported into the Partek Genomics Suite software (Partek, 
8 
9 St. Louis, Missouri), quantile normalized and pre-processed using a built-in chromosomal segmentation 
10 
11 algorithm (Hawthorn et al, 2010). Individual chromosomal segments were defined as continuous regions 
12 
13 
covered by at least 10 consecutive microarray probes, a significant (p<0.001) and considerable (>0.3 
14 
15 
16 copies  on  average)  difference  between  the  CN  of  the  given  segment  and  neighboring  segments, 
17 
18 accepting  an  error  rate  of  less  than  +/-  0.3  copies.  Segmented  genomes  were  subjected  to 
19 
20 Multidimensional Scaling (MDS) to describe inter-sample relationships. Partek’s One-Way and Two-Way 
21 
22 
23 RM ANOVA analyses were performed on segment CNs to identify CNAs different between individual 
24 
25 patients, CNAs consistently changed in consecutive metastases of the same patient, and CNAs between 
26 




studies analyzing a mixed-gender group of patients, X and Y chromosome-related data were excluded 
31 
32 from all such analyses. Significant differences were identified with a nominal p<0.05 and were corrected 
33 
34 with FDR of <0.05. Homozygous deletions (-/-) were identified as segments with CN<0.4 at an error rate 
35 
36 of <+/- 0.3 copies. 
37 
38 
39 Affymetrix gene expression data were imported to Partek Genomic Suite, quantile normalized 
40 
41 and  batch-corrected  using  Distance-Weighted-Discrimination,  as  described  elsewhere  (Benito  et  al, 
42 
43 2004). MDS, One-Way and Two-Way RM ANOVA analyses were performed as above. CN and GX data 
44 
45 
46 were integrated and analyzed with help of Partek Genomic Suite. Genes whose expression levels were 
47 
48 found to be affected by CNAs were identified by computing Pearson’s correlation between CN and GX 
49 




























Cells were harvested non-enzymatically using Cellstripper (Corning, Manassas, VA), and stained 
8 
9 with LIVE/DEAD Kit (Life Technologies, Carlsbad, CA), anti-CD117(KIT)-APC (BD Biosciences, San Jose, 
10 
11 CA), or isotype controls. Data analysis was performed using a MACSQuant Analyser (Miltenyi Biotec, 
12 
13 
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Multidimensional   Scaling  (MDS).   Metastases   are  symbolized   by   spheres.  Recurrent   metastases 
belonging  to  the  same  patient  (A-H)  are  color-coded;  non-recurrent,  random  metastasis  samples, 
serving as controls, are grey. Panel b) shows distribution of MDS plot distances between individual 





















15 Description  and basic characterization  of the analyzed  sample set by integrated  copy number and 
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22 Panel  a)  shows  frequency  and  spatial  distribution  of  autosomal  CN  aberrations  in  the  analyzed 
23 
24 melanoma sample set. Panel b) displays combined distribution analysis of CN gains and losses affecting 
25 
26 key melanoma genes, and also their distribution between various, disease-related biological functions, 
27 
28 
29 as defined by the Ingenuity Pathway Analysis database.  Selected key melanoma genes are labeled with 
30 








































3 distances (~genomic differences) between recurrent metastases belonging to the same, vs. different 
4 
5 
6 patients are shown. P-values given are derived from a standard t-test considering all possible recurrent 
7 
8 metastasis pairs from the sample set. Panels c) and d) display similar information on whole genome RNA 
9 










Identification of stable individual traits conserved in recurrent metastases of a given patient through 
21 




26 On panel a), examples are shown for stable conserved copy number traits that remain characteristic for 
27 
28 
29 a given case of recurrent melanoma (selected examples in yellow frames). Samples belonging to the 
30 
31 same patient  are aligned horizontally and color coded (to the left).   On panel b), conserved gene 
32 
33 expression patterns, characteristic for a given case, remain stable throughout multiple recurrences and 
34 
35 
36 are shown using a standardized heatmap (selected examples in yellow frames). Samples are aligned 
37 
38 vertically and color coded (top). HUGO gene symbols of selected melanoma-related genes are shown to 
39 





















regions that, although completely lost at one time point of disease history (-/- = blue), months or years 











3 Panels a) and b) compare MDS-based distances (estimates of genomic difference) between first and last 
4 
5 
6 lesions of different patients experiencing multiple recurrences of melanoma. A standard t-test is applied 
7 
8 to test whether late lesions are less different from each other than earlier ones, that is, if there is 
9 
10 convergent evolution among individual cases of metastatic melanoma. Panels c) and d) analyze the 
11 
12 
question if subsequent recurrent recurrences (any nth and n+1th lesion) would be more and more distant 
14 
15 (~different) from  the first diagnosed metastasis, implying incremental changes and thus sequential 
16 



















36 Panel a) displays a histogram of the calculated DNA copy number values associated with every identified 
37 
38 chromosome segment in the analyzed melanoma sample set. A blue circle marks segments accepted as 
39 
40 homozygous deletions (-/-) considering the accuracy and statistical fidelity limits set for chromosomal 
41 
42 
segmentation. Panel b) displays the fate of these completely deleted segments in eight patients (A, B, 
44 
45 etc.), experiencing several melanoma recurrences in a sequence (A/1, A/2, B/1, B/2, etc.), some of which 
46 











































































































































































































































































































































































































































































































































































































































































































































GEO Microarray ID Disease course Patient ID Lesion ID Date of Primary Site of primary Applied therapy Date of metastasis Site of metastasis Local vs. Distant Date of death Gender Origin 





cutaneous, right arm 
 
 
TIL CELLS/IL2 HD, RADIATION (5000cGy, 3000cGy) DTIC/CDDP 
6/21/1989 subcutaneous, soft palate Distant 8/5/2002 F Surgery Branch, NIH, Bethesda, USA 
2 Recurrent A A/2a 6/10/1992 uterine metastasis Distant 8/5/2002 F Surgery Branch, NIH, Bethesda, USA 
3 Recurrent A A/2b 6/10/1992 uterine metastasis Distant 8/5/2002 F Surgery Branch, NIH, Bethesda, USA 
4 Recurrent A A/3a 9/30/2000 subcutaneous, R flank Distant 8/5/2002 F Surgery Branch, NIH, Bethesda, USA 
5 Recurrent A A/3b 9/30/2000 subcutaneous, R flank Distant 8/5/2002 F Surgery Branch, NIH, Bethesda, USA 
6 Recurrent A A/3c 9/30/2000 subcutaneous, R flank Distant 8/5/2002 F Surgery Branch, NIH, Bethesda, USA 
7 Recurrent A A/4 8/28/2001 subcutaneous, R breast Distant 8/5/2002 F Surgery Branch, NIH, Bethesda, USA 
8 Recurrent B B/1 
5/28/1985 cutaneous, left foot SURGERY, DTIC, IL2 
9/13/1999 abdominal subcutis Distant 11/26/2000 F CRO, Aviano, Italy 
9 Recurrent B B/2 7/26/2000 cutis of the leg Local 11/26/2000 F CRO, Aviano, Italy 
10 Recurrent C C/1  
8/12/1991 
 
cutaneous, right leg 
 
SURGERY, anti‐idiotype/IL‐2 
7/12/1993 in transit cutis/subcutis of the leg Local 2/1/1995 F CRO, Aviano, Italy 
11 Recurrent C C/2 3/23/1994 inguinal lymph nodes Local 2/1/1995 F CRO, Aviano, Italy 
12 Recurrent C C/3 1/17/1995 cutis/subcutis of the arm Distant 2/1/1995 F CRO, Aviano, Italy 
13 Recurrent D D/1 
9/28/1990 cutaneous, right arm SURGERY, DTIC 
5/15/1994 axillary lymph nodes Local 9/3/1998 M CRO, Aviano, Italy 
14 Recurrent D D/2 12/23/1997 pancreas Distant 9/3/1998 M CRO, Aviano, Italy 
15 Recurrent E E/1  
9/6/1994 
 
cutaneous, left leg 
 
SURGERY, DTIC 
8/30/1996 inguinal lymph nodes Local 6/30/2004 M CRO, Aviano, Italy 
16 Recurrent E E/2 6/19/1998 subcutis of the leg Local 6/30/2004 M CRO, Aviano, Italy 
17 Recurrent E E/3 4/20/1999 cutis/subcutis of the leg Local 6/30/2004 M CRO, Aviano, Italy 
18 Recurrent F F/1  
10/9/1995 
 
cutaneous, left knee 
GP100/MART‐1 VACC, TYROS/GP100 VACC,IL2 HD, 
DTIC/CDDP, CYTOXAN/FLUDARABINE/TIL  CELLS/IL2 HD, 
RADIATION, GAMMA KNIFE 
7/7/1999 chest wall (subcutaneous) Distant 4/25/2004 M Surgery Branch, NIH, Bethesda, USA 
19 Recurrent F F/2 6/21/2001 axilla Distant 4/25/2004 M Surgery Branch, NIH, Bethesda, USA 
20 Recurrent F F/3 3/6/2003 thigh (soft tissue ‐ muscle) Distant 4/25/2004 M Surgery Branch, NIH, Bethesda, USA 
21 Recurrent G G/1  
8/19/1997 
 
cutaneous, right calf 
IFNA, MELPHALAN WITH ILP, DTIC/CISPLATIN/VELBAN/IL‐ 
2/IFNA, gpGP100 VACC, IL2, CYTOXAN/FLUDARABINE/TIL 
CELLS/MART‐1 VACC/IL2 HD, VEMURAFENIB 
6/26/2001 pelvis Distant Alive M Surgery Branch, NIH, Bethesda, USA 
22 Recurrent G G/2 6/1/2002 thigh/buttock (subcutaneous) Distant Alive M Surgery Branch, NIH, Bethesda, USA 
23 Recurrent G G/3 1/14/2003 popliteal fossa Local Alive M Surgery Branch, NIH, Bethesda, USA 
24 Recurrent H H/1  
12/9/1999 
 
cutaneous, mid back 
IFNA/GM‐CSF/GP100 VACC/ MART‐1 VACC /GCSF, 
CYTOXAN/FLUDARABINE / TIL CELLS/IL2 HD/MART1 VACC, 
GCSF, DTIC/CDDP 
1/21/2002 back (subcutaneous) Local 10/4/2004 M Surgery Branch, NIH, Bethesda, USA 
25 Recurrent H H/2 7/14/2003 shoulder (soft tissue ‐ muscle) Distant 10/4/2004 M Surgery Branch, NIH, Bethesda, USA 
26 Recurrent H H/3 3/31/2004 axilla Distant 10/4/2004 M Surgery Branch, NIH, Bethesda, USA 
27 Random 1 1 N/A N/A N/A N/A N/A N/A N/A N/A Surgery Branch, NIH, Bethesda, USA 
28 Random 2 2 N/A N/A N/A N/A N/A N/A N/A N/A Surgery Branch, NIH, Bethesda, USA 
29 Random 3 3 N/A N/A N/A N/A N/A N/A N/A N/A Surgery Branch, NIH, Bethesda, USA 
30 Random 4 4 N/A N/A N/A N/A N/A N/A N/A N/A Surgery Branch, NIH, Bethesda, USA 
31 Random 5 5 N/A N/A N/A N/A N/A N/A N/A N/A Surgery Branch, NIH, Bethesda, USA 
32 Random 6 6 N/A N/A N/A N/A N/A N/A N/A N/A Surgery Branch, NIH, Bethesda, USA 
33 Random 7 7 N/A N/A N/A N/A N/A N/A N/A N/A Surgery Branch, NIH, Bethesda, USA 
34 Random 8 8 N/A N/A N/A N/A N/A N/A N/A N/A Surgery Branch, NIH, Bethesda, USA 
35 Random 9 9 N/A N/A N/A N/A N/A N/A N/A N/A Surgery Branch, NIH, Bethesda, USA 
36 Random 10 10 N/A N/A N/A N/A N/A N/A N/A N/A Surgery Branch, NIH, Bethesda, USA 
37 Random 11 11 N/A N/A N/A N/A N/A N/A N/A N/A Surgery Branch, NIH, Bethesda, USA 
38 Random 12 12 N/A N/A N/A N/A N/A N/A N/A N/A Surgery Branch, NIH, Bethesda, USA 
39 Random 13 13 N/A N/A N/A N/A N/A N/A N/A N/A Surgery Branch, NIH, Bethesda, USA 
40 Random 14 14 N/A N/A N/A N/A N/A N/A N/A N/A Surgery Branch, NIH, Bethesda, USA 
41 Random 15 15 N/A N/A N/A N/A N/A N/A N/A N/A Surgery Branch, NIH, Bethesda, USA 
42 Random 16 16 N/A N/A N/A N/A N/A N/A N/A N/A Surgery Branch, NIH, Bethesda, USA 
43 Random 17 17 N/A N/A N/A N/A N/A N/A N/A N/A Surgery Branch, NIH, Bethesda, USA 
44 Random 18 18 N/A N/A N/A N/A N/A N/A N/A N/A Surgery Branch, NIH, Bethesda, USA 
45 Random 19 19 N/A N/A N/A N/A N/A N/A N/A N/A Surgery Branch, NIH, Bethesda, USA 
46 Random 20 20 N/A N/A N/A N/A N/A N/A N/A N/A Surgery Branch, NIH, Bethesda, USA 
47 Random 21 21 N/A N/A N/A N/A N/A N/A N/A N/A Surgery Branch, NIH, Bethesda, USA 
48 Random 22 22 N/A N/A N/A N/A N/A N/A N/A N/A Surgery Branch, NIH, Bethesda, USA 
 



















































HUGO Gene Symbol % of samples  with deletions % samples  with amplifications Entrez Gene Name Location Type(s) Drug(s) Tumorigenesis Proliferation, Cell Cycle Survival Cell death, Apoptosis Angiogenesis Adhesion, Binding,  Attachment, Detachment Movement, Migration, Invasion Metastasis 
CDKN2A 90 0 cyclin-dependent kinase inhibitor  2A (me Nucleus transcription regulator 
 
+ - - + - - - - 
CDKN2B 81 0 cyclin-dependent kinase inhibitor  2B (p1 Nucleus transcription regulator 
 
- + - - - - - - 
IFNA2 81 4 interferon, alpha 2 Extracellular Space cytokine 
 
- + - - - - - - 
XIAP 75 2 X-linked  inhibitor  of apoptosis Cytoplasm other 
 
- - - + - - - - 
SAT1 73 8 spermidine/spermine N1-acetyltransfera sCytoplasm enzyme 
 
- - - + - - - - 
ITGB1 71 2 integrin,  beta 1 (fibronectin receptor, be Plasma Membrane transmembrane receptor 
 
- + - - - + + - 
FAS 67 2 Fas (TNF receptor  superfamily, member 6Plasma  Membrane transmembrane receptor 
 
- - - + - - - - 
PLAU 63 2 plasminogen activator, urokinase Extracellular Space peptidase 
 
- - - - + - - - 
CXCL12 63 4 chemokine (C-X-C motif) ligand 12 Extracellular Space cytokine 
 
- - - - - + + - 
RET 63 4 ret proto-oncogene Plasma Membrane kinase sunitinib + - - - - - - - 
CD274 63 10 CD274 molecule Plasma Membrane other 
 
+ - - - - - - + 
PTEN 60 2 phosphatase and tensin homolog Cytoplasm phosphatase 
 
+ - - - - - + - 
MAPK8 58 4 mitogen-activated protein  kinase 8 Cytoplasm kinase aplidine - - - - + - - - 
FLNA 58 6 filamin  A, alpha Cytoplasm other 
 
- - + - - - + - 
L1CAM 58 6 L1 cell adhesion molecule Plasma Membrane other 
 
- - - - - + + - 
POU3F2 58 6 POU class 3 homeobox 2 Nucleus transcription regulator 
 
- + - - - - - - 
SMPD2 58 6 sphingomyelin phosphodiesterase 2, neu Cytoplasm enzyme 
 
- - - - - + - - 
DNMBP 56 2 dynamin binding  protein Cytoplasm other 
 
- - - - - - + - 
FGF8 56 2 fibroblast growth  factor 8 (androgen-indu Extracellular Space growth  factor 
 
- - - - + - - - 
MGMT 56 6 O-6-methylguanine-DNA methyltransfera Nucleus enzyme O6-benzylg - - + - - - - - 
PMAIP1 56 6 phorbol-12-myristate-13-acetate-induced Cytoplasm other 
 
- - - + - - - - 
SMAD4 56 6 SMAD family member  4 Nucleus transcription regulator 
 
- + - - - - - - 
PLG 56 8 plasminogen Extracellular Space peptidase tenectepla + - - - + - - + 
CASP3 54 0 caspase  3, apoptosis-related cysteine  pe Cytoplasm peptidase IDN-6556 - - - + - - - - 
BCL2 54 6 B-cell CLL/lymphoma 2 Cytoplasm other oblimerse n - - + + - - - - 
CDH2 54 6 cadherin  2, type 1, N-cadherin (neuronal Plasma Membrane other 
 
- - - - - + - - 
SMAD7 54 6 SMAD family member  7 Nucleus transcription regulator 
 
- - - - - - + - 
ATM 54 10 ataxia telangiectasia mutated Nucleus kinase 
 
- + + + - - - - 
CTSL1 52 2 cathepsin L1 Cytoplasm peptidase 
 
+ - - - - - + - 
GADD45G 52 2 growth  arrest and DNA-damage-inducibl Nucleus other 
 
- - - + - - - - 
S1PR3 52 2 sphingosine-1-phosphate receptor  3 Plasma Membrane G-protein coupled  receptor fingolimod - - - - - - + - 
BAG1 52 6 BCL2-associated athanogene Cytoplasm other 
 
- - + - - - - - 
AKIRIN2 52 8 akirin 2 Nucleus other 
 
+ - - - - - - - 
LTBP2 50 2 latent transforming growth factor beta bi Extracellular Space other 
 
- - - - - - + - 
CRYAB 50 10 crystallin, alpha B Nucleus other 
 
- - - - + - - - 
IL18 50 10 interleukin 18 (interferon-gamma-inducin Extracellular Space cytokine 
 
- - - - + - - - 
BMP4 48 2 bone morphogenetic protein  4 Extracellular Space growth factor 
 
- - - - - - + - 
FGF2 48 2 fibroblast growth  factor 2 (basic) Extracellular Space growth  factor FCE 26644 + - - + - - - - 
IL2 48 2 interleukin 2 Extracellular Space cytokine 
 
- - - - + - - - 
PRKACG 48 2 protein  kinase, cAMP-dependent, catalyt Cytoplasm kinase 
 
- + - - - - - - 
SPP1 48 2 secreted  phosphoprotein 1 Extracellular Space cytokine 
 
- + - + - + + - 
TNC 48 2 tenascin  C Extracellular Space other 
 
- + - - - - - - 
BIRC2 48 13 baculoviral IAP repeat containing 2 Cytoplasm other 
 
- - - + - - - - 
CASP4 48 13 caspase  4, apoptosis-related cysteine  pe Cytoplasm peptidase 
 
- - - + - - - - 
ZBTB16 48 13 zinc finger and BTB domain  containing 16 Nucleus transcription regulator 
 
- - - - - - + - 
TFE3 48 15 transcription factor binding  to IGHM enh Nucleus transcription regulator 
 
- + - - - - - - 
AIMP1 46 2 aminoacyl tRNA synthetase complex-inte Extracellular Space cytokine 
 
- - + - - - - - 
ARHGAP5 46 2 Rho GTPase  activating protein  5 Cytoplasm enzyme 
 
- - - - - - + - 
GSN 46 2 gelsolin Extracellular Space other 
 
- - - - - - + - 
GZMB 46 2 granzyme B (granzyme 2, cytotoxic T-lym Cytoplasm peptidase 
 
- - - + - - - - 
RAPGEF2 46 2 Rap guanine  nucleotide exchange factor ( Cytoplasm other 
 
- + - + - - - - 
NOX4 46 13 NADPH oxidase  4 Cytoplasm enzyme 
 
+ + - - - - - - 
CXCL1 44 2 chemokine (C-X-C motif) ligand 1 (melan oExtracellular Space cytokine 
 
- + - - - - - - 
CXCL9 44 2 chemokine (C-X-C motif) ligand 9 Extracellular Space cytokine 
 
- - - - - + + - 
HSPA5 44 2 heat shock 70kDa protein  5 (glucose-reg Cytoplasm other 
 
- - - + - - - - 
MCAM 44 13 melanoma cell adhesion molecule Plasma Membrane other 
 
+ - + - - + + - 
IL8 42 2 interleukin 8 Extracellular Space cytokine 
 
+ - - + - - + - 
MMP14 42 2 matrix metallopeptidase 14 (membrane-i Extracellular Space peptidase 
 
- - - - - - + - 
STATH 42 2 statherin Nucleus other 
 
- - - - - + - - 
SPTAN1 40 4 spectrin,  alpha, non-erythrocytic 1 (alpha Plasma Membrane other 
 
- + - - - - - - 
CTSB 40 15 cathepsin B Cytoplasm peptidase 
 
- - - + - - + - 
PBK 40 17 PDZ binding  kinase Cytoplasm kinase 
 
- - - + - - - - 
KDR 38 4 kinase insert domain  receptor  (a type III r Plasma Membrane kinase AEE 788, s - - - - + - - - 
KIT 38 4 v-kit Hardy-Zuckerman 4 feline sarcoma  v Plasma Membrane kinase dasatinib, - + - - - - - - 
REST 38 4 RE1-silencing transcription factor Nucleus transcription regulator 
 
- - - + - - - - 
NRG1 38 15 neuregulin 1 Extracellular Space growth  factor 
 
- - - - - - + - 
PACS2 38 17 phosphofurin acidic cluster sorting protei Cytoplasm other 
 
- - - + - - - - 
PTK2B 38 17 PTK2B protein  tyrosine  kinase 2 beta Cytoplasm kinase 
 
- - - - - - + - 
TNFRSF10B 38 19 tumor necrosis  factor receptor  superfam Plasma Membrane transmembrane receptor tigatuzuma - - - + - - - - 
TNFRSF10C 38 19 tumor necrosis  factor receptor  superfam Plasma Membrane transmembrane receptor 
 
- - - + - - - - 
TNFRSF10D 38 19 tumor necrosis  factor receptor  superfam Plasma Membrane transmembrane receptor 
 
- - - + - - - - 
RHOC 35 13 ras homolog gene family, member  C Plasma  Membrane enzyme 
 
- - - - - - + - 
TRIM33 35 13 tripartite  motif containing 33 Nucleus transcription regulator 
 
- + - - - - - - 
HTATIP2 33 8 HIV-1 Tat interactive protein  2, 30kDa Nucleus transcription regulator 
 
- - - - + - - - 
CSRP3 33 10 cysteine  and glycine-rich protein  3 (cardia Nucleus other 
 
+ - - - - - - + 
TEAD1 33 10 TEA domain  family member  1 (SV40 trans Nucleus transcription regulator 
 
- + - + - - - - 
CYLD 33 13 cylindromatosis (turban  tumor syndrome Nucleus transcription regulator 
 
- + - - - - - - 
MMP2 33 13 matrix metallopeptidase 2 (gelatinase A, Extracellular Space peptidase 
 
- - - - + - + - 
NOL3 33 13 nucleolar protein  3 (apoptosis repressor  w Nucleus other 
 
- - - + - - - - 
CDH1 33 15 cadherin  1, type 1, E-cadherin (epithelial Plasma Membrane other 
 
- - - + - + + - 
CAT 31 8 catalase Cytoplasm enzyme 
 
- + - - - - - - 
WT1 31 8 Wilms tumor 1 Nucleus transcription regulator 
 
- - - + - - - - 
NGF 31 15 nerve growth  factor (beta polypeptide) Extracellular Space growth  factor 
 
- - - - - - + - 
IKBKB 31 17 inhibitor  of kappa light polypeptide gene Cytoplasm kinase 
 
- - - + - - - - 
CD44 29 8 CD44 molecule (Indian  blood group) Plasma Membrane other 
 
- + - - - + - - 
 








































HUGO Gene Symbol % of samples  with deletions % samples  with amplifications Entrez Gene Name Location Type(s) Drug(s) Tumorigenesis Proliferation, Cell Cycle Survival Cell death, Apoptosis Angiogenesis Adhesion, Binding,  Attachment, Detachment Movement, Migration, Invasion Metastasis 
TP53 29 8 tumor protein  p53 Nucleus transcription regulator 
 
+ - + + - - - - 
F3 29 10 coagulation factor III (thromboplastin, tis Plasma Membrane transmembrane receptor 
 
+ - - - - - - + 
XAF1 29 10 XIAP associated factor 1 Nucleus other 
 
- - - + - - - - 
JUN 29 13 jun proto-oncogene Nucleus transcription regulator 
 
- - - + - - - - 
ARRB1 29 17 arrestin,  beta 1 Cytoplasm other 
 
- + - - - - - - 
VCAM1 27 10 vascular  cell adhesion molecule 1 Plasma  Membrane other 
 
- - - - - - + - 
GADD45A 27 13 growth  arrest and DNA-damage-inducibl Nucleus other 
 
- - - + - - - - 
JAK1 27 13 Janus kinase 1 Cytoplasm kinase 
 
- + - - - - - - 
CCND1 27 15 cyclin D1 Nucleus other 
 
- + - - - - - - 
CAPN1 27 19 calpain  1, (mu/I) large subunit Cytoplasm peptidase 
 
- - - - - - + - 
FLT1 27 19 fms-related tyrosine  kinase 1 (vascular  en Plasma Membrane kinase sunitinib, p - - - - + - - - 
HDAC1 27 19 histone  deacetylase 1 Nucleus transcription regulator tributyrin, - - - + - - - - 
RBBP4 27 19 retinoblastoma binding  protein  4 Nucleus enzyme 
 
- - + - - - - - 
DCT 27 23 dopachrome tautomerase (dopachrome Cytoplasm enzyme 
 
- - - + - - - - 
ING1 27 23 inhibitor  of growth  family, member  1 Nucleus transcription regulator 
 
- + - - - - - - 
APAF1 25 10 apoptotic peptidase activating factor 1 Cytoplasm other 
 
- - - + - - - - 
ITGA1 25 10 integrin,  alpha 1 Plasma Membrane other 
 
- - - - + - - - 
ITGA2 25 10 integrin,  alpha 2 (CD49B,  alpha 2 subunit Plasma Membrane other 
 
+ - - - - + + + 
BANP 25 13 BTG3 associated nuclear  protein Nucleus other 
 
- + - - - - - - 
RPS6KA1 25 15 ribosomal protein  S6 kinase, 90kDa, poly Cytoplasm kinase 
 
- - + - - - - - 
YBX1 25 17 Y box binding  protein  1 Nucleus transcription regulator 
 
- - - + - - - - 
MAPK7 23 10 mitogen-activated protein  kinase 7 Cytoplasm kinase 
 
- - - - + - - - 
VCAN 23 10 versican Extracellular Space other 
 
- + - - - + - - 
BCAR1 23 13 breast cancer anti-estrogen resistance 1 Plasma Membrane other 
 
- - - - - - + - 
EFNA5 23 13 ephrin-A5 Plasma Membrane kinase 
 
- - - - - + - - 
CSF2 23 15 colony stimulating factor 2 (granulocyte- Extracellular Space cytokine 
 
- + - - - - - - 
WASF2 23 15 WAS protein  family, member  2 Cytoplasm other 
 
- - - - - - + - 
F2R 21 8 coagulation factor II (thrombin) receptor Plasma Membrane G-protein coupled  receptor chrysalin, a - - - - - + - - 
F2R 21 8 coagulation factor II (thrombin) receptor Plasma Membrane G-protein coupled  receptor chrysalin, + - - - - - - + 
PAWR 21 10 PRKC, apoptosis, WT1, regulator Nucleus transcription regulator 
 
- - - + - - - - 
CSNK1A1 21 17 casein kinase 1, alpha 1 Cytoplasm kinase 
 
- + - + - - - - 
SPARC 21 17 secreted  protein,  acidic, cysteine-rich (os Extracellular Space other 
 
- - - - - - + - 
SCARB1 21 19 scavenger receptor  class B, member  1 Plasma  Membrane transporter 
 
- - - - - + - - 
CASC1 21 21 cancer susceptibility candidate 1 Cytoplasm other 
 
- + - - - - - - 
RAPGEF3 19 13 Rap guanine  nucleotide exchange factor ( Nucleus other 
 
- - - - - - + - 
ATF1 19 17 activating transcription factor 1 Nucleus transcription regulator 
 
- - - + - - - - 
EGR1 19 17 early growth  response 1 Nucleus transcription regulator 
 
- + - + - - - - 
PHLDA1 19 17 pleckstrin homology-like domain,  family A Cytoplasm other 
 
- - - + - - - - 
IFNG 19 19 interferon, gamma Extracellular Space cytokine 
 
- + - + + - - - 
HSPB8 19 21 heat shock 22kDa protein  8 Cytoplasm kinase 
 
- - - + - - - - 
PXN 19 21 paxillin Cytoplasm other 
 
- - - - - - + - 
CASP9 19 23 caspase  9, apoptosis-related cysteine  pe Cytoplasm peptidase 
 
- - - + - - - - 
DIABLO 19 23 diablo,  IAP-binding mitochondrial protein Cytoplasm other 
 
- - - + - - - - 
PEBP1 19 23 phosphatidylethanolamine binding  prote Cytoplasm other 
 
- - - + - - - - 
PEBP1 19 23 phosphatidylethanolamine binding  protei Cytoplasm other 
 
- - - - - - + - 
RAP1GAP 19 23 RAP1 GTPase  activating protein Cytoplasm other 
 
- - - - - - + - 
CDKN1B 19 25 cyclin-dependent kinase inhibitor  1B (p2 Nucleus other 
 
- - - + - - + - 
MX1 17 17 myxovirus (influenza virus) resistance 1, i Nucleus enzyme 
 
- - - - - - + - 
STAT1 17 17 signal transducer and activator  of transcr Nucleus transcription regulator 
 
+ - - - - - - - 
ITGA5 17 19 integrin,  alpha 5 (fibronectin receptor,  al Plasma Membrane other 
 
- - - - - + + - 
COL4A3 17 21 collagen,  type IV, alpha 3 (Goodpasture a Extracellular Space other collagenas - + - - - - + - 
GSTM1 17 21 glutathione S-transferase mu 1 Cytoplasm enzyme 
 
+ + + + - - - - 
PMEL 17 21 premelanosome protein Plasma Membrane enzyme 
 
- + - - - - - - 
BCL2L10 17 23 BCL2-like 10 (apoptosis facilitator) Cytoplasm other 
 
- - - + - - - - 
PAX3 17 23 paired box 3 Nucleus transcription regulator 
 
- - - + - - - - 
B4GALNT1 17 27 beta-1,4-N-acetyl-galactosaminyl transfe Cytoplasm enzyme 
 
- - - - + - - - 
DDIT3 17 27 DNA-damage-inducible transcript 3 Nucleus transcription regulator 
 
- - - + - - - - 
CTBP1 15 13 C-terminal binding  protein  1 Nucleus enzyme 
 
- - - - - - + - 
CASP8 15 15 caspase  8, apoptosis-related cysteine  pe pNucleus peptidase 
 
- - - + - - - - 
CFLAR 15 15 CASP8 and FADD-like apoptosis regulator Cytoplasm other 
 
- - - + - - - - 
FN1 15 15 fibronectin 1 Plasma  Membrane enzyme 
 
+ - - - - + + + 
ITGA4 15 17 integrin,  alpha 4 (antigen  CD49D,  alpha 4 Plasma Membrane other natalizuma - - - - - + + - 
PLCL1 15 17 phospholipase C-like 1 Cytoplasm enzyme 
 
- - - - - - + - 
ATF2 15 19 activating transcription factor 2 Nucleus transcription regulator 
 
+ + + + - - - + 
ITGA6 15 19 integrin,  alpha 6 Plasma Membrane other 
 
- - - - - + - - 
ITGAV 15 19 integrin,  alpha V (vitronectin receptor,  al Plasma Membrane other abciximab + - + + - + + + 
COL18A1 15 21 collagen,  type XVIII, alpha 1 Extracellular Space other collagenas e + - - - - - - + 
SHC4 15 23 SHC (Src homology 2 domain  containing) Cytoplasm other 
 
- - - - - - + - 
LTBR 15 31 lymphotoxin beta receptor  (TNFR superf Plasma Membrane transmembrane receptor 
 
- - - - + - - - 
PPARG 15 31 peroxisome proliferator-activated recept Nucleus ligand-dependent nuclear  receptor pioglitazon - + - - - - - - 
RAF1 15 31 v-raf-1 murine leukemia  viral oncogene h Cytoplasm kinase sorafenib - + - - - - - - 
VWF 15 31 von Willebrand factor Extracellular Space other 
 
- - - - - + - - 
WNT5A 15 35 wingless-type MMTV integration site fam Extracellular Space cytokine 
 
+ - - - - - + - 
DPP4 13 19 dipeptidyl-peptidase 4 Plasma Membrane peptidase saxagliptin + - + - - - - - 
THBS1 13 23 thrombospondin 1 Extracellular Space other 
 
- - - - - + - - 
ADAM10 13 27 ADAM metallopeptidase domain  10 Plasma Membrane peptidase 
 
- - - - - - + - 
FLNB 13 33 filamin  B, beta Cytoplasm other 
 
- - - + - - - - 
SKI 13 33 v-ski sarcoma  viral oncogene homolog (av Nucleus transcription regulator 
 
- + - - - - + - 
LTF 13 35 lactotransferrin Extracellular Space peptidase 
 
- - - - - + - - 
ITPR1 13 38 inositol  1,4,5-triphosphate receptor,  type Cytoplasm ion channel 
 
- - - - - - + - 
RPSA 13 38 ribosomal protein  SA Cytoplasm translation regulator 
 
- - - - - + + - 
GAS6 13 42 growth  arrest-specific 6 Extracellular Space growth factor 
 
- + + - - - - - 
ITGA9 13 42 integrin,  alpha 9 Plasma Membrane other 
 
- - - - - + - - 
VTN 10 10 vitronectin Extracellular Space other 
 
- - - - - - + - 
CCR7 10 13 chemokine (C-C motif) receptor  7 Plasma Membrane G-protein coupled  receptor 
 
- - - - - - + - 
 



















































HUGO Gene Symbol % of samples  with deletions % samples  with amplifications Entrez Gene Name Location Type(s) Drug(s) Tumorigenesis Proliferation, Cell Cycle Survival Cell death, Apoptosis Angiogenesis Adhesion, Binding,  Attachment, Detachment Movement, Migration, Invasion Metastasis 
ERBB2 10 13 v-erb-b2  erythroblastic leukemia  viral on Plasma Membrane kinase trastuzum - - - - + - - - 
CXCR4 10 15 chemokine (C-X-C motif) receptor  4 Plasma Membrane G-protein coupled  receptor plerixafor - - - - - - + - 
ICOS 10 17 inducible T-cell co-stimulator Plasma Membrane other 
 
- - - - - + - - 
IL1A 10 17 interleukin 1, alpha Extracellular Space cytokine IL-1 trap - + - + - - - - 
IL1B 10 17 interleukin 1, beta Extracellular Space cytokine IL-1 trap, c - + - - - - - - 
IL1RN 10 17 interleukin 1 receptor  antagonist Extracellular Space cytokine 
 
+ + - - - - - - 
KIDINS220 10 19 kinase D-interacting substrate, 220kDa Nucleus transcription regulator 
 
- + - + - - - - 
RRM2 10 19 ribonucleotide reductase M2 Nucleus enzyme gemcitabi - - - - + - - - 
CNN1 10 29 calponin 1, basic, smooth  muscle Cytoplasm other 
 
+ - - - - - + + 
EPOR 10 29 erythropoietin receptor Plasma Membrane transmembrane receptor darbepoet - - - + - - - - 
IGF1R 10 29 insulin-like growth  factor 1 receptor Plasma Membrane transmembrane receptor OSI-906,  c - - - + - - - - 
CSPG4 10 31 chondroitin sulfate proteoglycan 4 Plasma Membrane other 
 
- - - - - - + - 
PRKACA 10 33 protein  kinase, cAMP-dependent, catalyt Cytoplasm kinase 
 
- + - - - - - - 
RHOA 10 40 ras homolog gene family, member  A Cytoplasm enzyme 
 
- - - - - - + - 
ENPP2 10 42 ectonucleotide pyrophosphatase/phosph Plasma Membrane enzyme 
 
- - - - - - + - 
TGFB2 10 50 transforming growth  factor, beta 2 Extracellular Space growth  factor AP-12009 - - - - - - + - 
STAT3 8 15 signal transducer and activator  of transcr Nucleus transcription regulator 
 
- + - + - - + - 
PLK1 8 17 polo-like  kinase 1 Nucleus kinase BI 2536 - - - + - - - - 
POMC 8 19 proopiomelanocortin Extracellular Space other 
 
- - - - - + - - 
MAPK3 8 21 mitogen-activated protein  kinase 3 Cytoplasm kinase 
 
- + - - - - - - 
RND3 8 21 Rho family GTPase  3 Cytoplasm enzyme 
 
- - - - - - + - 
AXL 8 27 AXL receptor  tyrosine  kinase Plasma Membrane kinase 
 
- + + - - - - - 
DNASE1 8 27 deoxyribonuclease I Extracellular Space enzyme 
 
- - - + - - - - 
MAP2K1 8 27 mitogen-activated protein  kinase kinase 1 Cytoplasm kinase PD 032590 - - - + - - - - 
MIA 8 27 melanoma inhibitory activity Extracellular Space other 
 
- + - + - - + - 
TGFB1 8 27 transforming growth  factor, beta 1 Extracellular Space growth factor 
 
- + - - - + + - 
AKT1S1 8 29 AKT1 substrate 1 (proline-rich) Cytoplasm other 
 
- - - + - - - - 
BAX 8 29 BCL2-associated X protein Cytoplasm other 
 
- - - + - - - - 
BBC3 8 29 BCL2 binding  component 3 Cytoplasm other 
 
- - - + - - - - 
MAPK9 8 29 mitogen-activated protein  kinase 9 Cytoplasm kinase 
 
- - - - + - - - 
PPP1R15A 8 29 protein  phosphatase 1, regulatory (inhibi Cytoplasm other 
 
- - - + - - - - 
SDCBP 8 33 syndecan binding  protein  (syntenin) Plasma Membrane enzyme 
 
- - - - - - + - 
TP73 8 33 tumor protein  p73 Nucleus transcription regulator 
 
- - - - + - - - 
TYK2 8 33 tyrosine  kinase 2 Plasma Membrane kinase 
 
- + - - - - - - 
MMP16 8 38 matrix metallopeptidase 16 (membrane-i Extracellular Space peptidase 
 
- - - - - - + - 
MUC4 8 38 mucin 4, cell surface  associated Extracellular Space growth  factor 
 
- - - + - + - - 
CHRD 8 40 chordin Extracellular Space other 
 
- - - - - - + - 
HMOX1 8 40 heme oxygenase (decycling) 1 Cytoplasm enzyme tin mesopo - + - - - - - - 
KNG1 8 40 kininogen 1 Extracellular Space other 
 
- - - - - + - - 
MFI2 8 40 antigen  p97 (melanoma associated) ident Plasma Membrane other 
 
- - - - - - + - 
TNFSF10 8 40 tumor necrosis  factor (ligand)  superfami Extracellular Space cytokine 
 
- - - + - - - - 
MYC 8 44 v-myc myelocytomatosis viral oncogene h Nucleus transcription regulator 
 
+ + - + + - - - 
NOV 8 44 nephroblastoma overexpressed gene Extracellular Space growth factor 
 
- - - - - - + - 
TERT 8 44 telomerase reverse  transcriptase Nucleus enzyme GRN163L + + + + - - - - 
PRNP 8 46 prion protein Plasma Membrane other 
 
- - - - - - + - 
SIRPA 8 46 signal-regulatory protein  alpha Plasma Membrane phosphatase 
 
- - - - - - + - 
SMOX 8 46 spermine oxidase Cytoplasm enzyme 
 
- - - + - - - - 
WISP1 8 46 WNT1 inducible signaling  pathway  protei Extracellular Space other 
 
+ - - - - - - + 
TASP1 8 50 taspase,  threonine aspartase, 1 Nucleus peptidase 
 
- + - + - - - - 
IL10 8 52 interleukin 10 Extracellular Space cytokine 
 
- + + - - - - - 
IL24 8 52 interleukin 24 Extracellular Space cytokine 
 
- - - + - - - - 
CDKN1A 8 58 cyclin-dependent kinase inhibitor  1A (p2 1Nucleus other 
 
- + - + - - - - 
MAPK14 8 58 mitogen-activated protein  kinase 14 Cytoplasm kinase SCIO-469, - + - + - - - - 
CHST10 6 19 carbohydrate sulfotransferase 10 Cytoplasm enzyme 
 
- - - - - - + - 
MAP4K4 6 19 mitogen-activated protein  kinase kinase k Cytoplasm kinase 
 
- - - - - - + - 
SLC4A1 6 29 solute carrier family 4, anion exchanger, Plasma Membrane transporter 
 
- - - - - + - - 
ALCAM 6 38 activated  leukocyte cell adhesion molecul Plasma Membrane other 
 
- - - - - + - - 
CD47 6 38 CD47 molecule Plasma Membrane other 
 
- - - - - + + - 
OSM 6 38 oncostatin M Extracellular Space cytokine 
 
- + - - - - - - 
PTK2 6 44 PTK2 protein  tyrosine  kinase 2 Cytoplasm kinase 
 
- - - - - + - - 
MGAT1 6 50 mannosyl (alpha-1,3-)-glycoprotein beta- Cytoplasm enzyme 
 
- - - - - + - - 
FASLG 6 52 Fas ligand (TNF superfamily, member  6) Extracellular Space cytokine 
 
- - - + - - + - 
GCLC 6 52 glutamate-cysteine ligase, catalytic  subun Cytoplasm enzyme 
 
- - + - - - - - 
SELP 6 52 selectin  P (granule  membrane protein  14 Plasma Membrane other 
 
- - - - - + - - 
KISS1 6 54 KiSS-1 metastasis-suppressor Cytoplasm other 
 
+ - - - - - - + 
VEGFA 6 58 vascular  endothelial growth  factor A Extracellular Space growth  factor bevacizum + - - - + - - - 
DEK 6 60 DEK oncogene Nucleus transcription regulator 
 
- - - + - - - - 
EDN1 6 60 endothelin 1 Extracellular Space other 
 
- - - - - - + - 
LTA 6 60 lymphotoxin alpha (TNF superfamily, me Extracellular Space cytokine 
 
+ - - - - - - + 
THBD 6 60 thrombomodulin Plasma Membrane transmembrane receptor 
 
- - - - - + - - 
TNF 6 60 tumor necrosis  factor Extracellular Space cytokine adalimum - - - + - - - - 
IL6 6 65 interleukin 6 (interferon, beta 2) Extracellular Space cytokine tocilizumab - + - - - + - - 
PTP4A3 6 65 protein  tyrosine  phosphatase type IVA, m Plasma Membrane phosphatase 
 
- + - - - + + - 
LSP1 4 27 lymphocyte-specific protein  1 Cytoplasm other 
 
- - - - - - + - 
BRSK2 4 31 BR serine/threonine kinase 2 unknown kinase 
 
- + - - - - - - 
CD151 4 31 CD151 molecule (Raph blood group) Plasma Membrane other 
 
- - - - - - + - 
DNAJA3 4 33 DnaJ (Hsp40)  homolog, subfamily A, mem Cytoplasm other 
 
- + - - - - - - 
HOXB7 4 33 homeobox B7 Nucleus transcription regulator 
 
- + - - - - - - 
ITGA3 4 33 integrin,  alpha 3 (antigen  CD49C,  alpha 3 Plasma Membrane other 
 
- - - - - + - - 
ITGB3 4 33 integrin,  beta 3 (platelet  glycoprotein IIIa Plasma Membrane transmembrane receptor TP 9201, E + - + + - + + + 
AGTR1 4 42 angiotensin II receptor,  type 1 Plasma Membrane G-protein coupled  receptor amlodipin - - - - + - - - 
IL12A 4 46 interleukin 12A (natural  killer cell stimula Extracellular Space cytokine 
 
- - - - + - - - 
BIK 4 50 BCL2-interacting killer (apoptosis-inducin Cytoplasm other 
 
- - - + - - - - 
TXNIP 4 50 thioredoxin interacting protein Cytoplasm other 
 
+ - - - - - - + 
MCL1 4 52 myeloid  cell leukemia  sequence 1 (BCL2-r Cytoplasm transporter 
 
- - - + - - - - 
 




















































HUGO Gene Symbol % of samples  with deletions % samples  with amplifications Entrez Gene Name Location Type(s) Drug(s) Tumorigenesis Proliferation, Cell Cycle Survival Cell death, Apoptosis Angiogenesis Adhesion, Binding,  Attachment, Detachment Movement, Migration, Invasion Metastasis 
ADAM15 4 54 ADAM metallopeptidase domain  15 Plasma Membrane peptidase 
 
- - - - - + - - 
DDR2 4 54 discoidin domain  receptor  tyrosine  kinase Plasma Membrane kinase 
 
- + - - - - - - 
EFNA1 4 54 ephrin-A1 Plasma Membrane other 
 
- - - - + - - - 
CD36 4 56 CD36 molecule (thrombospondin recepto Plasma Membrane transmembrane receptor 
 
- - - - - - + - 
CCND3 4 58 cyclin D3 Nucleus other 
 
- + - - - - - - 
PRKCA 2 44 protein  kinase C, alpha Cytoplasm kinase L-threo-saf - - - - - - + - 
SPHK1 2 44 sphingosine kinase 1 Cytoplasm kinase 
 
- - - + - - + - 
HGF 2 67 hepatocyte growth factor (hepapoietin A Extracellular Space growth  factor 
 
- - - + - - - - 
HGF 2 67 hepatocyte growth factor (hepapoietin A; Extracellular Space growth  factor 
 
- - - - - - + - 
NRCAM 2 73 neuronal cell adhesion molecule Plasma Membrane other 
 
- - - - - - + - 
EPO 2 77 erythropoietin Extracellular Space cytokine 
 
- - - + - - + - 
LEP 2 77 leptin Extracellular Space growth  factor 
 
- + - - - - - - 
SERPINE1 2 77 serpin peptidase inhibitor, clade E (nexin Extracellular Space other drotrecogi - - - - + - - - 
BRAF 2 85 v-raf murine  sarcoma  viral oncogene hom Cytoplasm enzyme sorafenib - + + - - - + - 
NOS3 2 85 nitric oxide synthase  3 (endothelial cell) Cytoplasm enzyme GW 27362 + - - - - - - + 
PKMYT1 0 42 protein  kinase, membrane associated tyr Cytoplasm kinase 
 
- - - + - - - - 
BIRC5 0 44 baculoviral IAP repeat containing 5 Cytoplasm other 
 
+ - - - - - - - 
TIMP2 0 46 TIMP metallopeptidase inhibitor  2 Extracellular Space other 
 
- - - - - - + - 
FASN 0 48 fatty acid synthase Cytoplasm enzyme 
 
- + - - - - - - 
HGS 0 48 hepatocyte growth factor-regulated tyros Cytoplasm other 
 
- + - - - - - - 
P4HB 0 50 prolyl 4-hydroxylase, beta polypeptide Cytoplasm enzyme 
 
- - - + - - - - 
SRC 0 75 v-src sarcoma  (Schmidt-Ruppin A-2) viral Cytoplasm kinase dasatinib, - - - + - - - - 
CD40 0 77 CD40 molecule, TNF receptor  superfamil Plasma Membrane transmembrane receptor SGN-40  (an - + - - - - - - 
MMP9 0 77 matrix metallopeptidase 9 (gelatinase B, Extracellular Space peptidase 
 
- - - - - - + - 
CSE1L 0 79 CSE1 chromosome segregation 1-like (ye Nucleus transporter 
 
+ - - - - - - + 
BIRC7 0 88 baculoviral IAP repeat containing 7 Cytoplasm other 
 
- - - + - - - - 
LAMA5 0 88 laminin,  alpha 5 Extracellular Space other 
 
+ - - + + - + + 
 
































































































Chromosome cytoband  Start  Stop  Nominal p-value  FDR           length (bps)          Total Amplifications          Amplification Average Copy Number        Samples with Amplification Total Deletions          Deletion Average Copy Number       Samples with Deletion  Total Aberrations      Total Unchanged 
1 1q24.2  167549043        167571390 5,87E-05  0,000866875  22348  26 3,27985  10 11 12 15 16 18 19 20 21 22 23 24 25 26 27 29 32 34 35 36 39 40 42 43 45 47 2 1,64918  8 14 28 20 
1 1q24.2  167571390        167606344 5,87E-05  0,000866875  34955  26 3,19567  10 11 12 15 16 18 19 20 21 22 23 24 25 26 27 29 32 34 35 36 39 40 42 43 45 47 2 1,64918  8 14 28 20 
1 1q24.2  167606344        167618519 5,87E-05  0,000866875  12176  26 2,94368  10 11 12 15 16 18 19 20 21 22 23 24 25 26 27 29 32 34 35 36 39 40 42 43 45 47 2 1,64918  8 14 28 20 
1        1q24.2 - 1q25.2  167618519        178375347 6,13E-05  0,000894545         10756829  25 2,95053  10 11 12 15 18 19 20 21 22 23 24 25 26 27 29 32 34 35 36 39 40 42 43 45 47 3 1,58223  8 14 16 28 20 
1 1q25.3  178624120        179822871 5,54E-05  0,000830233           1198752  25 2,94731  10 11 12 15 18 19 20 21 22 23 24 25 26 27 29 32 34 35 36 39 40 42 43 45 47 3 1,58223  8 14 16 28 20 
1        1q25.3 - 1q31.1  180126375        184543632 5,20E-05  0,000799827           4417258  25 2,94731  10 11 12 15 18 19 20 21 22 23 24 25 26 27 29 32 34 35 36 39 40 42 43 45 47 3 1,58223  8 14 16 28 20 
1 1q31.1  184543632        185412170 5,20E-05  0,000799827  868539  24 2,97255  10 11 12 15 18 19 20 21 22 23 24 25 26 27 29 34 35 36 39 40 42 43 45 47 3 1,58223  8 14 16 27 21 
1 1q31.1  185412170        185582619 5,20E-05  0,000799827  170450  23 2,99504  10 11 12 15 18 19 20 21 22 23 24 25 26 27 29 34 35 36 39 42 43 45 47 3 1,58223  8 14 16 26 22 
1        1q31.1 - 1q31.2  185582619        190567298 5,20E-05  0,000799827           4984680  23 2,99504  10 11 12 15 18 19 20 21 22 23 24 25 26 27 29 34 35 36 39 42 43 45 47 3 1,58223  8 14 16 26 22 
1 1q31.2  190567298        191078486 5,20E-05  0,000799827  511189  24 2,97428  10 11 12 15 18 19 20 21 22 23 24 25 26 27 29 34 35 36 39 40 42 43 45 47 3 1,58223  8 14 16 27 21 
1 1q31.2  191372033        191691062 5,46E-05  0,00082484 319030  24 2,97428  10 11 12 15 18 19 20 21 22 23 24 25 26 27 29 34 35 36 39 40 42 43 45 47 3 1,53425  8 14 16 27 21 
1        1q31.2 - 1q31.3  191691062        194822570 5,46E-05  0,00082484 3131509  23 2,99504  10 11 12 15 18 19 20 21 22 23 24 25 26 27 29 34 35 36 39 42 43 45 47 3 1,53425  8 14 16 26 22 
1        1q41 - 1q42.13  221829600        226558551 1,98E-07  6,82E-05  4728952  23 2,93637  10 11 12 18 19 20 21 22 23 24 25 26 27 29 32 34 35 36 39 40 42 43 45 8 1,46627  8 13 14 15 16 31 41 47 31 17 
1 1q42.13  226719912        226732899 1,32E-07  6,82E-05  12988  23 3,03017  10 11 12 18 19 20 21 22 23 24 25 26 27 29 32 34 35 36 39 40 42 43 45 8 1,46627  8 13 14 15 16 31 41 47 31 17 
1       1q42.13  - 1q42.2  226732899        228988418 1,32E-07  6,82E-05  2255520  23 2,92551  10 11 12 18 19 20 21 22 23 24 25 26 27 29 32 34 35 36 39 40 42 43 45 8 1,46627  8 13 14 15 16 31 41 47 31 17 
1 1q42.2  228988418        229892270 2,14E-06  0,000171693  903853  22 2,95193  10 11 12 18 19 20 21 22 23 24 26 27 29 32 34 35 36 39 40 42 43 45 8 1,46627  8 13 14 15 16 31 41 47 30 18 
1 1q42.2  229892270        229915153 5,54E-05  0,000830233  22884  22 2,95193  10 11 12 18 19 20 21 22 23 24 26 27 29 32 34 35 36 39 40 42 43 45 10 1,37709  5 7 8 13 14 15 16 31 41 47 32 16 
1 1q42.2  229915153        229934501 7,35E-06  0,000190706  19349  22 2,95193  10 11 12 18 19 20 21 22 23 24 26 27 29 32 34 35 36 39 40 42 43 45 13 1,26599  1 2 5 6 7 8 13 14 15 16 31 41 47 35 13 
1 1q42.2  229934501        230279270 3,66E-07  9,70E-05  344770  22 2,95193  10 11 12 18 19 20 21 22 23 24 26 27 29 32 34 35 36 39 40 42 43 45 14 1,24733  1 2 4 5 6 7 8 13 14 15 16 31 41 47 36 12 
1 1q42.2  230279270        231411430 2,33E-05  0,000428846           1132161  23 2,93936  6 10 11 12 18 19 20 21 22 23 24 26 27 29 32 34 35 36 39 40 42 43 45 8 1,46627  8 13 14 15 16 31 41 47 31 17 
1        1q42.2 - 1q42.3  231411430        234073195 1,68E-06  0,000171693           2661766  22 2,95193  10 11 12 18 19 20 21 22 23 24 26 27 29 32 34 35 36 39 40 42 43 45 8 1,46627  8 13 14 15 16 31 41 47 30 18 
1          1q42.3 - 1q43  234073195        234788348 1,68E-06  0,000171693  715154  23 2,97486  10 11 12 18 19 20 21 22 23 24 26 27 29 32 34 35 36 39 40 42 43 45 47 7 1,49333  8 13 14 15 16 31 41 30 18 
1 1q43  234788348        234847183 1,68E-06  0,000171693  58836  23 3,05131  10 11 12 18 19 20 21 22 23 24 26 27 29 32 34 35 36 39 40 42 43 45 47 7 1,49333  8 13 14 15 16 31 41 30 18 
1 1q43  234847183        235073018 1,68E-06  0,000171693  225836  23 3,05131  10 11 12 18 19 20 21 22 23 24 26 27 29 32 34 35 36 39 40 42 43 45 47 6 1,53438  8 13 14 15 16 31 29 19 
1 1q43  235073018        235210904 1,68E-06  0,000171693  137887  23 2,98229  10 11 12 18 19 20 21 22 23 24 26 27 29 32 34 35 36 39 40 42 43 45 47 6 1,53438  8 13 14 15 16 31 29 19 
1 1q43  235210904        235284808 1,58E-06  0,000171693  73905  23 2,98229  10 11 12 18 19 20 21 22 23 24 26 27 29 32 34 35 36 39 40 42 43 45 47 6 1,49116  8 13 14 15 16 31 29 19 
1 1q43  235569369        236124544 1,96E-06  0,000171693  555176  22 3,01138  10 11 12 18 19 20 21 22 23 26 27 29 32 34 35 36 39 40 42 43 45 47 6 1,49116  8 13 14 15 16 31 28 20 
1 1q43  236124544        236320923 1,96E-06  0,000171693  196380  22 3,09862  10 11 12 18 19 20 21 22 23 26 27 29 32 34 35 36 39 40 42 43 45 47 6 1,49116  8 13 14 15 16 31 28 20 
1 1q43  236320923        236819468 1,96E-06  0,000171693  498546  22 3,09862  10 11 12 18 19 20 21 22 23 26 27 29 32 34 35 36 39 40 42 43 45 47 6 1,49116  8 13 14 15 16 31 28 20 
1 1q43  236819468        238243880 1,96E-06  0,000171693           1424413  22 3,00733  10 11 12 18 19 20 21 22 23 26 27 29 32 34 35 36 39 40 42 43 45 47 6 1,49116  8 13 14 15 16 31 28 20 
1 1q43  238243880        238530190 7,92E-06  0,000191764  286311  22 3,00733  10 11 12 18 19 20 21 22 23 26 27 29 32 34 35 36 39 40 42 43 45 47 6 1,36752  8 13 14 15 16 31 28 20 
1 1q43  238530190        239281160 7,92E-06  0,000191764  750971  22 3,04139  10 11 12 18 19 20 21 22 23 26 27 29 32 34 35 36 39 40 42 43 45 47 6 1,36752  8 13 14 15 16 31 28 20 
1 1q43  239281160        239425690 7,92E-06  0,000191764  144531  22 3,00539  10 11 12 18 19 20 21 22 23 26 27 29 32 34 35 36 39 40 42 43 45 47 6 1,36752  8 13 14 15 16 31 28 20 
1 1q43  239425690        239527732 7,92E-06  0,000191764  102043  22 3,00539  10 11 12 18 19 20 21 22 23 26 27 29 32 34 35 36 39 40 42 43 45 47 6 1,36752  8 13 14 15 16 31 28 20 
1 1q43  239527732        239860403 1,94E-06  0,000171693  332672  22 3,00539  10 11 12 18 19 20 21 22 23 26 27 29 32 34 35 36 39 40 42 43 45 47 6 1,49281  8 13 14 15 16 31 28 20 
4 4q21.1  78147832            78304252  6,00E-05  0,000878529  156421  1 2,34065  18 22 1,4876  8 9 14 15 16 24 25 26 27 28 29 30 31 32 33 34 36 40 43 44 45 48 23 25 
4 4q22.1  93833262            93920215  6,13E-08  6,82E-05  86954  1 2,34065  18 25 1,35728  8 9 10 11 12 14 15 16 23 24 26 27 28 29 30 31 32 33 34 36 40 43 44 46 48 26 22 
4        4q22.1 - 4q22.2  93920215            94026249  6,13E-08  6,82E-05  106035  1 2,34065  18 25 1,32744  8 9 10 11 12 14 15 16 23 24 26 27 28 29 30 31 32 33 34 36 40 43 44 46 48 26 22 
4 4q22.2  94026249            94043491  9,17E-07  0,000171693  17243  1 2,34065  18 25 1,34016  8 9 10 11 12 14 15 16 23 24 26 27 28 29 30 31 32 33 34 36 40 43 44 46 48 26 22 
5 5q14.3  82857645            83303986  4,23E-06  0,000173307  446342  5 2,46604  15 16 24 25 26 11 1,59211  8 14 18 19 20 31 32 34 36 40 43 16 32 
5 5q14.3  83303986            83355082  2,87E-05  0,0005135  51097  6 2,44179  1 15 16 24 25 26 11 1,59211  8 14 18 19 20 31 32 34 36 40 43 17 31 
5 5q14.3  83355082            84566238  2,87E-05  0,0005135  1211157  6 2,44179  1 15 16 24 25 26 11 1,56198  8 14 18 19 20 31 32 34 36 40 43 17 31 
5 5q14.3  84566238            84798044  5,44E-05  0,00082484 231807  6 2,55179  1 15 16 24 25 26 11 1,56198  8 14 18 19 20 31 32 34 36 40 43 17 31 
5 5q14.3  84798044            85417863  7,79E-06  0,000191764  619820  6 2,63201  1 15 16 24 25 26 11 1,56198  8 14 18 19 20 31 32 34 36 40 43 17 31 
5 5q14.3  85417863            90208286  7,79E-06  0,000191764           4790424  6 2,63201  1 15 16 24 25 26 11 1,58157  8 14 18 19 20 31 32 34 36 40 43 17 31 
5          5q14.3 - 5q15  90508445            93558039  1,15E-05  0,000248423           3049595  6 2,63201  1 15 16 24 25 26 11 1,58157  8 14 18 19 20 31 32 34 36 40 43 17 31 
5          5q15 - 5q21.1  93930505         100522215 8,26E-06  0,000198199           6591711  6 2,63201  1 15 16 24 25 26 11 1,58698  8 14 18 19 20 31 32 34 36 40 43 17 31 
5        5q21.1 - 5q21.2  101581405        104344033 8,29E-06  0,000198199           2762629  6 2,63201  1 15 16 24 25 26 11 1,58698  8 14 18 19 20 31 32 34 36 40 43 17 31 
5        5q21.2 - 5q21.3  104344033        105350570 7,07E-05  0,000995102           1006538  6 2,52363  1 15 16 24 25 26 11 1,58698  8 14 18 19 20 31 32 34 36 40 43 17 31 
5        5q21.3 - 5q23.1  105350570        120081981 3,23E-05  0,000553553         14731412  6 2,43638  1 15 16 24 25 26 11 1,58698  8 14 18 19 20 31 32 34 36 40 43 17 31 
5 5q23.1  120081981        121320288 3,23E-05  0,000553553           1238308  7 2,46382  1 15 16 24 25 26 36 10 1,5855  8 14 18 19 20 31 32 34 40 43 17 31 
5        5q23.1 - 5q23.2  121320288        122787427 3,23E-05  0,000553553           1467140  7 2,46382  1 15 16 24 25 26 36 11 1,55067  8 14 18 19 20 31 32 34 40 43 47 18 30 
5 5q23.2  122787427        123282827 3,23E-05  0,000553553  495401  7 2,46382  1 15 16 24 25 26 36 10 1,5855  8 14 18 19 20 31 32 34 40 43 17 31 
5        5q23.2 - 5q31.1  123282827        131089080 3,23E-05  0,000553553           7806254  7 2,46382  1 15 16 24 25 26 36 11 1,5486  8 14 18 19 20 31 32 34 40 43 47 18 30 
5 5q31.1  131089080        133534214 3,23E-05  0,000553553           2445135  7 2,46382  1 15 16 24 25 26 36 11 1,56401  8 14 18 19 20 31 32 34 40 43 47 18 30 
5 5q31.1  133534214        133739648 3,23E-05  0,000553553  205435  8 2,58256  1 15 16 24 25 26 36 38 11 1,56401  8 14 18 19 20 31 32 34 40 43 47 19 29 
5 5q31.1  133739648        133939701 3,23E-05  0,000553553  200054  7 2,46382  1 15 16 24 25 26 36 11 1,56401  8 14 18 19 20 31 32 34 40 43 47 18 30 
5 5q31.1  134414015        134454265 1,58E-06  0,000171693  40251  8 2,53538  1 15 16 17 24 25 26 36 11 1,56401  8 14 18 19 20 31 32 34 40 43 47 19 29 
5 5q31.1  134454265        134509512 1,58E-06  0,000171693  55248  8 2,53538  1 15 16 17 24 25 26 36 10 1,60245  8 14 18 19 20 31 32 34 40 43 18 30 
5 5q31.1  134509512        134679639 1,77E-06  0,000171693  170128  8 2,57818  1 15 16 17 24 25 26 36 10 1,60245  8 14 18 19 20 31 32 34 40 43 18 30 
5 5q34  165107405        165204424 1,87E-06  0,000171693  97020  10 2,62545  1 15 16 18 19 20 24 25 26 36 7 1,61451  8 14 31 32 34 38 43 17 31 
5 5q34  165669205        165820375 4,84E-05  0,000768626  151171  9 2,80761  15 16 18 19 20 24 25 26 36 12 1,47745  1 2 5 6 7 8 14 31 32 34 38 43 21 27 
5 5q34  165820375        166781934 4,84E-05  0,000768626  961560  9 2,80761  15 16 18 19 20 24 25 26 36 13 1,46032  1 2 5 6 7 8 14 31 32 34 38 43 45 22 26 
5 5q35.3  180492584        180644840 4,56E-05  0,000742503  152257  12 2,54506  1 15 18 19 20 22 23 24 25 26 36 40 8 1,56569  8 11 14 31 32 38 39 42 20 28 
6 6p21.32  32577063            32646913  8,83E-06  0,000208715  69851  27 4,21953  5 10 11 12 13 14 16 17 18 19 20 21 22 23 26 30 34 35 36 37 38 39 42 43 46 47 48 10 1,35788  3 15 24 27 28 29 31 32 40 44 37 11 
6 6p21.32  32646913            32666562  7,78E-06  0,000191764  19650  29 4,11846  3 5 10 11 12 13 14 16 17 18 19 20 21 22 23 26 30 34 35 36 37 38 39 42 43 44 46 47 48 8 1,3595  15 24 27 28 29 31 32 40 37 11 
6 6p21.32  32666562            32696414  7,78E-06  0,000191764  29853  31 4,0377  3 5 10 11 12 13 14 16 17 18 19 20 21 22 23 26 28 29 30 34 35 36 37 38 39 42 43 44 46 47 5 1,34149  15 24 27 32 40 36 12 
6 6p21.32  32696414            32725906  3,53E-06  0,000171693  29493  31 3,53076  3 5 10 11 12 13 14 16 17 18 19 20 21 22 23 26 28 29 30 32 34 35 36 38 39 42 43 44 46 47 4 1,43095  15 24 27 40 35 13 
6 6p21.32  32725906            32755558  3,53E-06  0,000171693  29653  31 3,53076  3 5 10 11 12 13 14 16 17 18 19 20 21 22 23 26 28 29 30 32 34 35 36 38 39 42 43 44 46 47 4 1,57238  15 24 27 40 35 13 
6 6q13  74610279            75233066  7,24E-06  0,000189168  622788  8 2,67869  3 10 11 12 14 16 29 44 21 1,40449  8 9 15 18 19 20 21 22 23 26 27 33 34 35 36 38 41 43 46 47 48 29 19 
6 6q13  75233066            75797327  7,24E-06  0,000189168  564262  8 2,67869  3 10 11 12 14 16 29 44 21 1,38404  8 9 15 18 19 20 21 22 23 26 27 33 34 35 36 38 41 43 46 47 48 29 19 
6          6q13 - 6q14.1  75797327            77256850  7,24E-06  0,000189168           1459524  8 2,67869  3 10 11 12 14 16 29 44 21 1,40342  8 9 15 18 19 20 21 22 23 26 27 33 34 35 36 38 41 43 46 47 48 29 19 
7 7q11.21  65353359            65748424  4,69E-06  0,000173307  395066  27 2,84903  3 8 9 10 11 12 13 14 16 17 18 19 20 24 25 26 29 31 33 34 38 39 40 43 46 47 48 4 1,59535  7 22 32 36 31 17 
7 7q11.21  65748424            65951441  4,69E-06  0,000173307  203018  27 2,89589  3 8 9 10 11 12 13 14 16 17 18 19 20 24 25 26 29 31 33 34 38 39 40 43 46 47 48 4 1,59535  7 22 32 36 31 17 
7     7q11.21  - 7q11.22  65951441            69116350  4,69E-06  0,000173307           3164910  26 2,89398  3 8 9 10 11 12 13 14 16 17 18 19 20 24 25 26 29 31 33 34 38 39 40 43 46 47 4 1,59535  7 22 32 36 30 18 
7 7q11.22  69116350            69402857  4,69E-06  0,000173307  286508  26 2,89398  3 8 9 10 11 12 13 14 16 17 18 19 20 24 25 26 29 31 33 34 38 39 40 43 46 47 5 1,57018  7 22 27 32 36 31 17 
7 7q11.22  69402857            69556543  4,69E-06  0,000173307  153687  25 2,90611  3 8 9 10 11 12 13 14 16 17 18 19 20 24 25 26 29 33 34 38 39 40 43 46 47 7 1,53979  7 22 27 28 31 32 36 32 16 
7 7q11.22  69556543            69621487  1,33E-05  0,000268788  64945  25 2,87885  3 8 9 10 11 12 13 14 16 17 18 19 20 24 25 26 29 33 34 38 39 40 43 46 47 7 1,53979  7 22 27 28 31 32 36 32 16 
7 7q11.22  69621487            69850553  1,33E-05  0,000268788  229067  26 2,8742  3 8 9 10 11 12 13 14 16 17 18 19 20 24 25 26 29 31 33 34 38 39 40 43 46 47 4 1,59535  7 22 32 36 30 18 
7 7q11.22  69850553            70379093  4,89E-06  0,000173307  528541  26 2,89293  3 8 9 10 11 12 13 14 16 17 18 19 20 24 25 26 29 31 33 34 38 39 40 43 46 47 4 1,59535  7 22 32 36 30 18 
7 7q11.22  70409236            70666575  5,25E-07  0,000122604  257340  23 2,8658  3 8 9 13 14 16 17 18 19 20 24 25 26 29 31 33 34 38 39 40 43 46 47 6 1,47201  7 11 12 22 32 36 29 19 
7 7q11.22  70666575            70991064  5,16E-06  0,000173307  324490  26 2,89472  3 8 9 10 11 12 13 14 16 17 18 19 20 24 25 26 29 31 33 34 38 39 40 43 46 47 4 1,59535  7 22 32 36 30 18 
7 7q11.22  70991064            71038531  3,68E-06  0,000171693  47468  26 2,89472  3 8 9 10 11 12 13 14 16 17 18 19 20 24 25 26 29 31 33 34 38 39 40 43 46 47 3 1,61214  7 32 36 29 19 
7 7q11.22  71038531            71054109  6,62E-06  0,000181226  15579  26 2,91802  3 8 9 10 11 12 13 14 16 17 18 19 20 24 25 26 29 31 33 34 38 39 40 43 46 47 3 1,61214  7 32 36 29 19 
7 7q11.22  71054109            71067232  4,41E-06  0,000173307  13124  26 2,93175  3 8 9 10 11 12 13 14 16 17 18 19 20 24 25 26 29 31 33 34 38 39 40 43 46 47 3 1,61214  7 32 36 29 19 
7 7q11.22  71067232            71462207  3,02E-05  0,000537041  394976  26 2,97903  3 8 9 10 11 12 13 14 16 17 18 19 20 24 25 26 29 31 33 34 38 39 40 43 46 47 3 1,61214  7 32 36 29 19 
7 7q11.22  71462207            71520322  4,40E-05  0,000722357  58116  26 2,97903  3 8 9 10 11 12 13 14 16 17 18 19 20 24 25 26 29 31 33 34 38 39 40 43 46 47 3 1,61214  7 32 36 29 19 
7     7q11.22  - 7q11.23  71520322            72012969  4,40E-05  0,000722357  492648  27 2,9685  3 8 9 10 11 12 13 14 16 17 18 19 20 24 25 26 29 31 33 34 38 39 40 43 46 47 48 3 1,61214  7 32 36 30 18 
7 7q11.23  72012969            72641094  4,40E-05  0,000722357  628126  29 2,94972  3 8 9 10 11 12 13 14 16 17 18 19 20 24 25 26 29 31 33 34 38 39 40 43 44 45 46 47 48 3 1,61214  7 32 36 32 16 
7 7q11.23  72641094            75080051  4,40E-05  0,000722357           2438958  29 2,96583  3 8 9 10 11 12 13 14 16 17 18 19 20 24 25 26 29 31 33 34 38 39 40 43 44 45 46 47 48 3 1,61214  7 32 36 32 16 
7 7q11.23  75080051            75272618  4,40E-05  0,000722357  192568  29 3,04167  3 8 9 10 11 12 13 14 16 17 18 19 20 24 25 26 29 31 33 34 38 39 40 43 44 45 46 47 48 3 1,61214  7 32 36 32 16 
7 7q11.23  75272618            75330849  4,40E-05  0,000722357  58232  29 2,9713  3 8 9 10 11 12 13 14 16 17 18 19 20 24 25 26 29 31 33 34 38 39 40 43 44 45 46 47 48 3 1,61214  7 32 36 32 16 
7 7q11.23  75330849            75415470  4,40E-05  0,000722357  84622  30 2,96207  3 8 9 10 11 12 13 14 16 17 18 19 20 24 25 26 29 31 33 34 38 39 40 42 43 44 45 46 47 48 3 1,61214  7 32 36 33 15 
7 7q11.23  75787126            75800988  7,12E-05  0,000995102  13863  29 3,12583  3 8 9 10 11 12 13 14 16 17 18 19 20 24 25 26 29 31 33 34 38 39 40 43 44 45 46 47 48 3 1,61214  7 32 36 32 16 
7 7q11.23  75800988            75979950  7,12E-05  0,000995102  178963  28 2,92745  3 8 9 10 11 12 13 14 16 17 18 19 20 24 25 26 29 31 33 34 38 39 40 43 44 45 47 48 3 1,61214  7 32 36 31 17 
7 7q11.23  75979950            76040010  7,12E-05  0,000995102  60061  28 2,91089  3 8 9 10 11 12 13 14 16 17 18 19 20 24 25 26 29 31 33 34 38 39 40 43 44 45 47 48 3 1,61214  7 32 36 31 17 
7 7q11.23  76040010            76174461  7,12E-05  0,000995102  134452  27 2,92707  3 8 9 10 11 12 13 14 16 17 18 19 20 24 25 26 29 31 33 34 38 39 40 43 44 47 48 3 1,61214  7 32 36 30 18 
7 7q11.23  76174461            76451814  7,12E-05  0,000995102  277354  26 2,94979  3 8 9 10 11 12 13 14 16 17 18 19 20 24 25 26 29 31 33 34 38 39 40 43 47 48 3 1,61214  7 32 36 29 19 
7 7q11.23  76451814            77053177  7,12E-05  0,000995102  601364  26 2,94979  3 8 9 10 11 12 13 14 16 17 18 19 20 24 25 26 29 31 33 34 38 39 40 43 47 48 2 1,60752  7 36 28 20 




















































Chromosome cytoband  Start  Stop  Nominal p-value  FDR           length (bps)          Total Amplifications          Amplification Average Copy Number        Samples with Amplification Total Deletions          Deletion Average Copy Number       Samples with Deletion  Total Aberrations      Total Unchanged 
8 8q11.23  53316167            53651879  1,91E-05  0,000354362  335713  18 2,9898  8 9 10 11 13 14 15 16 17 18 19 25 34 38 40 42 43 47 4 1,61834  31 32 33 36 22 26 
9 9p24.3  153160  479698  1,13E-05  0,000247263  326539  5 2,50387  24 25 27 39 40 31 1,36055  3 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 28 29 31 32 34 35 36 37 38 41 43 44 45 36 12 
9 9p24.3  479698  968532  1,13E-05  0,000247263  488835  5 2,50387  24 25 27 39 40 30 1,37273  3 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 28 29 31 32 34 35 36 37 38 41 43 44 48 35 13 
9 9p24.3  968532  1142263  1,13E-05  0,000247263  173732  5 2,50387  24 25 27 39 40 30 1,33807  3 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 28 29 31 32 34 35 36 37 38 41 43 44 48 35 13 
9 9p24.3  1142263  1215225  1,13E-05  0,000247263  72963  5 2,50387  24 25 27 39 40 30 1,37104  3 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 28 29 31 32 34 35 36 37 38 41 43 44 48 35 13 
9 9p24.3  1215225  1518403  1,13E-05  0,000247263  303179  5 2,50387  24 25 27 39 40 30 1,35589  3 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 28 29 31 32 34 35 36 37 38 41 43 44 48 35 13 
9 9p24.3  1518403  1743078  1,13E-05  0,000247263  224676  5 2,50387  24 25 27 39 40 31 1,35962  3 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 28 29 31 32 34 35 36 37 38 41 43 44 46 36 12 
9 9p24.3  1743078  2196519  1,13E-05  0,000247263  453442  6 2,62511  24 25 27 39 40 45 31 1,35962  3 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 28 29 31 32 34 35 36 37 38 41 43 44 46 37 11 
9        9p24.3 - 9p24.2  2196519  3070871  1,13E-05  0,000247263  874353  5 2,50387  24 25 27 39 40 31 1,35962  3 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 28 29 31 32 34 35 36 37 38 41 43 44 46 36 12 
9 9p24.2  3070871  3853784  1,13E-05  0,000247263  782914  5 2,50387  24 25 27 39 40 32 1,3451  3 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 28 29 31 32 34 35 36 37 38 41 43 44 45 37 11 
9 9p24.2  4092276  4181841  1,55E-05  0,000294498  89566  5 2,50387  24 25 27 39 40 32 1,3451  3 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 28 29 31 32 34 35 36 37 38 41 43 44 45 37 11 
9        9p24.2 - 9p24.1  4181841  4744597  1,55E-05  0,000294498  562757  5 2,73575  24 25 27 39 40 32 1,3451  3 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 28 29 31 32 34 35 36 37 38 41 43 44 45 37 11 
9 9p21.3  21836522            21849188  4,80E-05  0,000768333  12667  1 2,78151  27 42 0,850882  2 3 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 28 29 30 31 32 33 34 3 43 5 
9 9p21.3  21849188            21863450  4,80E-05  0,000768333  14263  1 2,78151  27 43 0,838348  2 3 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 28 29 30 31 32 33 34 3 44 4 
9 9p21.3  21863450            21883255  4,80E-05  0,000768333  19806  1 2,78151  27 43 0,812508  2 3 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 28 29 30 31 32 33 34 3 44 4 
9 9p21.3  21998815            22012740  5,84E-05  0,000866875  13926  0 ? 39 0,764042  2 3 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 24 25 26 27 28 29 30 31 32 34 36 37 3 39 9 
9 9p21.3  22012740            22051651  4,88E-05  0,000768626  38912  0 ? 38 0,811066  2 3 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 24 25 26 27 28 29 31 32 34 36 37 38 4 38 10 
9 9p21.3  22169618            22259388  4,56E-05  0,000742503  89771  0 ? 38 0,976016  2 3 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 24 25 26 27 28 29 31 32 34 36 37 38 4 38 10 
9 9p21.3  22259388            22344256  2,48E-06  0,000171693  84869  1 2,87494  27 36 1,09553  2 3 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 24 25 26 28 29 31 32 36 37 38 40 41 4 37 11 
9 9p21.3  22344256            22677460  1,81E-06  0,000171693  333205  1 2,87494  27 36 1,0909  2 3 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 24 25 26 28 29 31 32 36 37 38 40 41 4 37 11 
9 9p21.3  22677460            23194640  2,87E-06  0,000171693  517181  1 2,87494  27 36 1,09811  2 3 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 24 25 26 28 29 31 32 36 37 38 40 41 4 37 11 
9 9p21.3  23194640            23250421  8,79E-06  0,000208715  55782  1 2,87494  27 36 1,11642  2 3 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 24 25 26 28 29 31 32 36 37 38 40 41 4 37 11 
9 9p21.3  23250421            23665151  1,10E-05  0,000247263  414731  1 2,87494  27 36 1,09286  2 3 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 24 25 26 28 29 31 32 36 37 38 40 41 4 37 11 
9 9p21.3  23665151            23883374  1,42E-05  0,000280107  218224  1 2,87494  27 36 1,0976  2 3 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 24 25 26 28 29 31 32 36 37 38 40 41 4 37 11 
9 9p21.3  23883374            23996963  1,10E-05  0,000247263  113590  1 2,87494  27 36 1,09263  2 3 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 24 25 26 28 29 31 32 36 37 38 40 41 4 37 11 
9 9p21.3  23996963            24048126  7,49E-06  0,000190706  51164  1 2,87494  27 36 1,08777  2 3 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 24 25 26 28 29 31 32 36 37 38 40 41 4 37 11 
9 9p21.3  24048126            24184595  7,49E-06  0,000190706  136470  1 2,87494  27 36 1,12264  2 3 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 24 25 26 28 29 31 32 36 37 38 40 41 4 37 11 
9 9p21.3  24184595            24774630  5,67E-06  0,000173307  590036  1 2,87494  27 36 1,11825  2 3 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 24 25 26 28 29 31 32 36 37 38 40 41 4 37 11 
9        9p21.2 - 9p21.1  28040629            28130875  2,23E-07  6,82E-05  90247  1 2,87494  27 31 1,30837  3 8 9 10 11 12 13 15 16 17 18 19 20 21 24 25 26 28 29 31 32 36 37 38 40 41 43 44 45 46 32 16 
9 9p21.1  28130875            28192442  2,23E-07  6,82E-05  61568  1 2,87494  27 31 1,31233  3 8 9 10 11 12 13 15 16 17 18 19 20 21 24 25 26 28 29 31 32 36 37 38 40 41 43 44 45 46 32 16 
9 9p21.1  28192442            28297300  2,23E-07  6,82E-05  104859  0 ? 31 1,31233  3 8 9 10 11 12 13 15 16 17 18 19 20 21 24 25 26 28 29 31 32 36 37 38 40 41 43 44 45 46 31 17 
10 10q21.2  64047641            64294703  6,92E-05  0,000991895  247063  1 2,30166  32 33 1,39961  8 9 10 11 12 13 15 16 17 18 19 20 21 22 23 26 27 28 29 30 31 33 35 36 37 38 40 41 43 45 34 14 
11     11p15.5  - 11p15.4  2323434  2855107  1,98E-07  6,82E-05  531674  12 2,42297  8 13 16 22 26 28 32 36 37 42 44 46 6 1,32845  10 11 12 27 34 48 18 30 
11 11p15.4  2855107  2916660  1,98E-07  6,82E-05  61554  12 2,42297  8 13 16 22 26 28 32 36 37 42 44 46 7 1,37316  10 11 12 27 31 34 48 19 29 
11 11p15.4  3505200  3630287  1,65E-05  0,000310809  125088  7 2,40668  8 16 28 32 36 37 46 12 1,39051  10 11 12 15 19 20 21 27 29 31 34 48 19 29 
11 11p15.4  3630287  3641926  1,65E-05  0,000310809  11640  6 2,38774  8 16 28 32 36 37 14 1,40671  10 11 12 15 19 20 21 27 29 31 34 35 43 48 20 28 
11 11p15.4  3641926  3802858  9,32E-06  0,000218911  160933  6 2,38774  8 16 28 32 36 37 15 1,40886  10 11 12 15 19 20 21 23 27 29 31 34 35 43 48 21 27 
11 11p11.2  44225644            44618276  6,21E-05  0,000902609  392633  5 2,39534  8 15 16 28 36 13 1,55533  10 11 19 20 21 23 31 33 34 35 43 46 48 18 30 
11 11q11  55104986            55178839  4,05E-05  0,000689392  73854  25 3,66138  8 9 10 11 12 13 14 15 16 17 19 21 34 36 37 38 39 40 42 43 44 45 46 47 48 5 1,52876  3 23 28 30 31 30 18 
12 12q14.1  56329906            56427879  1,02E-06  0,000171693  97974  15 2,98972  1 8 10 11 12 14 16 22 24 25 32 40 41 45 46 8 1,59079  15 18 19 20 29 36 43 44 23 25 
12 12q14.1  56427879            56430465  2,96E-07  8,40E-05  2587  16 2,9548  1 8 10 11 12 14 15 16 22 24 25 32 40 41 45 46 7 1,5905  18 19 20 29 36 43 44 23 25 
12 12q14.1  56430465            56464185  3,54E-06  0,000171693  33721  22 3,07054  1 7 8 10 11 12 13 14 15 16 22 24 25 32 35 37 40 41 42 44 45 46 6 1,58907  18 19 20 29 36 43 28 20 
12 12q21.32  86954790            87025075  6,44E-06  0,000177634  70286  3 2,34497  14 24 25 13 1,48239  1 15 16 17 18 19 20 29 32 36 43 44 48 16 32 
12 12q21.32  87025075            87038759  6,44E-06  0,000177634  13685  3 2,34497  14 24 25 12 1,48897  1 15 16 17 18 19 20 29 36 43 44 48 15 33 
12 12q21.32  87038759            87142222  6,44E-06  0,000177634  103464  4 2,3579  14 24 25 40 12 1,50889  1 15 16 17 18 19 20 29 36 43 44 48 16 32 
12   12q21.32  - 12q21.33             87142222            88895228  7,15E-05  0,000996822           1753007  5 2,39313  1 14 24 25 40 11 1,49259  15 16 17 18 19 20 29 36 43 44 48 16 32 
12 12q23.1  96468826            97289459  7,75E-08  6,82E-05  820634  6 2,46641  14 22 24 25 40 41 12 1,50989  15 16 17 18 19 20 29 32 36 43 44 48 18 30 
12 12q23.1  97289459            97345781  4,95E-07  0,000122604  56323  6 2,46641  14 22 24 25 40 41 12 1,47465  15 16 17 18 19 20 29 32 36 43 44 48 18 30 
12 12q23.1  97549134            97809034  1,95E-07  6,82E-05  259901  5 2,49637  14 24 25 40 41 12 1,51932  15 16 17 18 19 20 29 32 36 43 44 48 17 31 
12 12q24.21  113572551        114831260 1,96E-06  0,000171693           1258710  9 2,53983  8 14 24 25 31 40 41 44 46 9 1,53257  15 16 17 18 19 20 29 36 43 18 30 
12 12q24.32  124525018        124566571 1,08E-05  0,000247263  41554  7 2,61564  14 25 31 40 41 44 46 11 1,54437  1 15 16 17 18 19 20 29 32 36 43 18 30 
12 12q24.32  124566571        124748151 1,08E-05  0,000247263  181581  7 2,61564  14 25 31 40 41 44 46 12 1,54041  1 15 16 17 18 19 20 29 32 36 43 48 19 29 
13   13q12.11  - 13q12.12             19112579            23161851  2,11E-06  0,000171693           4049273  8 2,63501  8 9 16 29 30 31 43 48 13 1,45228  14 18 19 20 21 23 24 25 26 28 35 36 40 21 27 
13 13q12.12  23597319            24328729  2,09E-06  0,000171693  731411  8 2,63501  8 9 16 29 30 31 43 48 13 1,4555  14 18 19 20 21 23 24 25 26 28 35 36 40 21 27 
13 13q12.12  24328729            24348103  2,09E-06  0,000171693  19375  7 2,61713  8 9 16 29 30 31 43 13 1,4555  14 18 19 20 21 23 24 25 26 28 35 36 40 20 28 
13   13q12.12  - 13q12.13             24348103            24410790  2,09E-06  0,000171693  62688  7 2,61713  8 9 16 29 30 31 43 14 1,43655  14 18 19 20 21 23 24 25 26 28 34 35 36 40 21 27 
13 13q12.13  24410790            24641266  2,09E-06  0,000171693  230477  8 2,61625  8 9 16 28 29 30 31 43 13 1,44847  14 18 19 20 21 23 24 25 26 34 35 36 40 21 27 
13 13q12.13  24641266            24642791  2,09E-06  0,000171693  1526  9 2,62652  8 9 16 28 29 30 31 43 48 13 1,44847  14 18 19 20 21 23 24 25 26 34 35 36 40 22 26 
13 13q12.13  24642791            26555431  2,09E-06  0,000171693           1912641  9 2,62652  8 9 16 28 29 30 31 43 48 13 1,48624  14 18 19 20 21 23 24 25 26 34 35 36 40 22 26 
13    13q12.13  - 13q12.2  26555431            26733305  4,48E-06  0,000173307  177875  8 2,66168  8 9 28 29 30 31 43 48 13 1,48624  14 18 19 20 21 23 24 25 26 34 35 36 40 21 27 
13     13q12.2  - 13q12.3  26733305            28491360  2,40E-06  0,000171693           1758056  9 2,63031  8 9 16 28 29 30 31 43 48 13 1,48624  14 18 19 20 21 23 24 25 26 34 35 36 40 22 26 
13 13q12.3  28491360            29118508  2,40E-06  0,000171693  627149  9 2,54473  8 9 16 28 29 30 31 43 48 13 1,48624  14 18 19 20 21 23 24 25 26 34 35 36 40 22 26 
13     13q12.3  - 13q13.1  29118508            31280839  2,40E-06  0,000171693           2162332  9 2,63103  8 9 16 28 29 30 31 43 48 13 1,48624  14 18 19 20 21 23 24 25 26 34 35 36 40 22 26 
13 13q13.1  31280839            31519948  4,43E-06  0,000173307  239110  9 2,63103  8 9 16 28 29 30 31 43 48 13 1,4139  14 18 19 20 21 23 24 25 26 34 35 36 40 22 26 
13 13q13.1  31519948            32819586  2,50E-06  0,000171693           1299639  9 2,63103  8 9 16 28 29 30 31 43 48 13 1,48725  14 18 19 20 21 23 24 25 26 34 35 36 40 22 26 
13     13q13.1  - 13q13.2  32819586            33107573  2,50E-06  0,000171693  287988  9 2,5368  8 9 16 28 29 30 31 43 48 13 1,48725  14 18 19 20 21 23 24 25 26 34 35 36 40 22 26 
13 13q13.2  33107573            34312359  2,50E-06  0,000171693           1204787  9 2,63321  8 9 16 28 29 30 31 43 48 13 1,48725  14 18 19 20 21 23 24 25 26 34 35 36 40 22 26 
13 13q13.2  34312359            34495929  2,50E-06  0,000171693  183571  9 2,63321  8 9 16 28 29 30 31 43 48 14 1,4752  14 18 19 20 21 23 24 25 26 34 35 36 40 47 23 25 
13 13q13.3  34848979            39159500  3,43E-06  0,000171693           4310522  9 2,63752  8 9 16 28 29 30 31 43 48 13 1,48725  14 18 19 20 21 23 24 25 26 34 35 36 40 22 26 
13 13q14.11  39578982            42674972  3,40E-06  0,000171693           3095991  9 2,63752  8 9 16 28 29 30 31 43 48 13 1,48725  14 18 19 20 21 23 24 25 26 34 35 36 40 22 26 
13 13q14.11  42922543            43283290  1,80E-05  0,000334731  360748  9 2,63752  8 9 16 28 29 30 31 43 48 13 1,42831  14 18 19 20 21 23 24 25 26 34 35 36 40 22 26 
13 13q14.11  43283290            43713363  3,61E-06  0,000171693  430074  9 2,63752  8 9 16 28 29 30 31 43 48 13 1,48914  14 18 19 20 21 23 24 25 26 34 35 36 40 22 26 
13   13q14.11  - 13q14.12             43984660            44717921  3,68E-06  0,000171693  733262  9 2,63752  8 9 16 28 29 30 31 43 48 13 1,49077  14 18 19 20 21 23 24 25 26 34 35 36 40 22 26 
13 13q14.12  44717921            44770079  4,99E-05  0,000782884  52159  9 2,63752  8 9 16 28 29 30 31 43 48 13 1,45432  14 18 19 20 21 23 24 25 26 34 35 36 40 22 26 
13    13q14.12  - 13q14.3  44999200            51474098  3,18E-06  0,000171693           6474899  9 2,63752  8 9 16 28 29 30 31 43 48 13 1,49349  14 18 19 20 21 23 24 25 26 34 35 36 40 22 26 
13     13q14.3  - 13q21.1  51474098            52330178  3,18E-06  0,000171693  856081  9 2,63752  8 9 16 28 29 30 31 43 48 13 1,49349  14 18 19 20 21 23 24 25 26 34 35 36 40 22 26 
13 13q21.1  52330178            52389636  3,18E-06  0,000171693  59459  9 2,63752  8 9 16 28 29 30 31 43 48 13 1,47458  14 18 19 20 21 23 24 25 26 34 35 36 40 22 26 
13 13q21.1  52389636            53086788  3,18E-06  0,000171693  697153  9 2,60744  8 9 16 28 29 30 31 43 48 13 1,47458  14 18 19 20 21 23 24 25 26 34 35 36 40 22 26 
13 13q21.1  53745801            53891133  7,22E-06  0,000189168  145333  9 2,58688  8 9 16 28 29 30 31 43 48 14 1,47053  14 18 19 20 21 23 24 25 26 34 35 36 40 41 23 25 
13 13q21.1  53891133            56628243  7,22E-06  0,000189168           2737111  9 2,58688  8 9 16 28 29 30 31 43 48 13 1,47458  14 18 19 20 21 23 24 25 26 34 35 36 40 22 26 
13 13q21.1  56628243            57120994  7,22E-06  0,000189168  492752  8 2,5778  8 9 16 28 29 30 43 48 14 1,48239  14 18 19 20 21 23 24 25 26 31 34 35 36 40 22 26 
13     13q21.1  - 13q21.2  57120994            60040881  7,22E-06  0,000189168           2919888  9 2,56891  8 9 16 28 29 30 31 43 48 13 1,47458  14 18 19 20 21 23 24 25 26 34 35 36 40 22 26 
13 13q21.31  61737974            63617064  6,34E-06  0,000177634           1879091  9 2,56891  8 9 16 28 29 30 31 43 48 13 1,47458  14 18 19 20 21 23 24 25 26 34 35 36 40 22 26 
13   13q21.31  - 13q21.32             63617064            64302477  6,34E-06  0,000177634  685414  10 2,5736  8 9 16 28 29 30 31 34 43 48 12 1,45736  14 18 19 20 21 23 24 25 26 35 36 40 22 26 
13 13q21.32  64302477            65574384  6,34E-06  0,000177634           1271908  9 2,56891  8 9 16 28 29 30 31 43 48 13 1,47279  14 18 19 20 21 23 24 25 26 34 35 36 40 22 26 
13 13q21.32  65574384            65820302  6,34E-06  0,000177634  245919  10 2,57771  8 9 16 28 29 30 31 39 43 48 13 1,47279  14 18 19 20 21 23 24 25 26 34 35 36 40 23 25 
13 13q21.32  65820302            66003338  6,34E-06  0,000177634  183037  10 2,57771  8 9 16 28 29 30 31 39 43 48 14 1,44605  14 18 19 20 21 23 24 25 26 27 34 35 36 40 24 24 
13   13q21.32  - 13q21.33             66003338            71135436  6,34E-06  0,000177634           5132099  10 2,57771  8 9 16 28 29 30 31 39 43 48 13 1,47279  14 18 19 20 21 23 24 25 26 34 35 36 40 23 25 
13 13q21.33  71135436            71385958  6,34E-06  0,000177634  250523  10 2,64006  8 9 16 28 29 30 31 39 43 48 13 1,47279  14 18 19 20 21 23 24 25 26 34 35 36 40 23 25 
13    13q21.33  - 13q22.3  71385958            77797354  6,34E-06  0,000177634           6411397  10 2,64006  8 9 16 28 29 30 31 39 43 48 13 1,48912  14 18 19 20 21 23 24 25 26 34 35 36 40 23 25 
13     13q22.3  - 13q31.1  77797354            78079319  6,14E-06  0,000177634  281966  10 2,7347  8 9 16 28 29 30 31 39 43 48 13 1,48912  14 18 19 20 21 23 24 25 26 34 35 36 40 23 25 
13 13q31.1  78079319            79581335  3,27E-06  0,000171693           1502017  10 2,6541  8 9 16 28 29 30 31 39 43 48 13 1,48912  14 18 19 20 21 23 24 25 26 34 35 36 40 23 25 
13 13q31.1  79581335            79946511  1,41E-05  0,000278255  365177  10 2,6541  8 9 16 28 29 30 31 39 43 48 13 1,45423  14 18 19 20 21 23 24 25 26 34 35 36 40 23 25 
13 13q31.1  79946511            80889482  3,29E-06  0,000171693  942972  10 2,6541  8 9 16 28 29 30 31 39 43 48 13 1,48802  14 18 19 20 21 23 24 25 26 34 35 36 40 23 25 
13 13q31.1  80889482            82549981  3,29E-06  0,000171693           1660500  10 2,6541  8 9 16 28 29 30 31 39 43 48 13 1,47177  14 18 19 20 21 23 24 25 26 34 35 36 40 23 25 
13 13q31.1  82549981            85049685  3,29E-06  0,000171693           2499705  11 2,64114  8 9 16 27 28 29 30 31 39 43 48 13 1,47177  14 18 19 20 21 23 24 25 26 34 35 36 40 24 24 
13 13q31.1  85358247            85731664  3,83E-06  0,000171693  373418  10 2,65875  8 9 16 27 28 29 30 39 43 48 13 1,47177  14 18 19 20 21 23 24 25 26 34 35 36 40 23 25 
13 13q31.1  85731664            85877092  5,25E-05  0,000802197  145429  10 2,65875  8 9 16 27 28 29 30 39 43 48 14 1,47204  10 14 18 19 20 21 23 24 25 26 34 35 36 40 24 24 
13 13q31.1  85877092            86413704  5,25E-05  0,000802197  536613  11 2,64597  8 9 16 27 28 29 30 31 39 43 48 14 1,47204  10 14 18 19 20 21 23 24 25 26 34 35 36 40 25 23 




















































Chromosome cytoband  Start  Stop  Nominal p-value  FDR           length (bps)          Total Amplifications          Amplification Average Copy Number        Samples with Amplification Total Deletions          Deletion Average Copy Number       Samples with Deletion  Total Aberrations      Total Unchanged 
13     13q31.2  - 13q31.3  88486215            91993239  3,89E-06  0,000171693           3507025  11 2,57447  8 9 16 27 28 29 30 31 39 43 48 13 1,47177  14 18 19 20 21 23 24 25 26 34 35 36 40 24 24 
13     13q31.3  - 13q32.1  91993239            95084294  3,89E-06  0,000171693           3091056  11 2,57447  8 9 16 27 28 29 30 31 39 43 48 13 1,48894  14 18 19 20 21 23 24 25 26 34 35 36 40 24 24 
13 13q32.1  95300442            95412851  3,82E-06  0,000171693  112410  11 2,57447  8 9 16 27 28 29 30 31 39 43 48 13 1,48894  14 18 19 20 21 23 24 25 26 34 35 36 40 24 24 
13     13q32.1  - 13q32.2  95412851            97395958  3,82E-06  0,000171693           1983108  10 2,58076  8 9 16 28 29 30 31 39 43 48 13 1,48894  14 18 19 20 21 23 24 25 26 34 35 36 40 23 25 
13     13q32.2  - 13q32.3  97633255            98506828  3,60E-06  0,000171693  873574  10 2,58076  8 9 16 28 29 30 31 39 43 48 13 1,49079  14 18 19 20 21 23 24 25 26 34 35 36 40 23 25 
13 13q32.3  98506828            99214870  1,67E-06  0,000171693  708043  9 2,59323  8 9 28 29 30 31 39 43 48 13 1,49079  14 18 19 20 21 23 24 25 26 34 35 36 40 22 26 
13 13q32.3  99214870            99412984  1,67E-06  0,000171693  198115  9 2,59323  8 9 28 29 30 31 39 43 48 12 1,50019  14 18 19 20 21 23 24 25 26 34 35 36 21 27 
13 13q32.3  99412984            99426056  1,67E-06  0,000171693  13073  9 2,59323  8 9 28 29 30 31 39 43 48 13 1,48576  14 18 19 20 21 23 24 25 26 34 35 36 40 22 26 
13 13q32.3  99426056            99771821  1,67E-06  0,000171693  345766  9 2,59323  8 9 28 29 30 31 39 43 48 14 1,47697  14 18 19 20 21 23 24 25 26 34 35 36 38 40 23 25 
13 13q32.3  99771821         100334884 1,67E-06  0,000171693  563064  9 2,59323  8 9 28 29 30 31 39 43 48 13 1,48576  14 18 19 20 21 23 24 25 26 34 35 36 40 22 26 
13     13q32.3  - 13q33.1             100334884        102708243 5,64E-06  0,000173307           2373360  10 2,58917  8 9 16 28 29 30 31 39 43 48 13 1,48576  14 18 19 20 21 23 24 25 26 34 35 36 40 23 25 
13     13q33.1  - 13q33.3             102708243        107627567 5,64E-06  0,000173307           4919325  11 2,59828  8 9 16 27 28 29 30 31 39 43 48 13 1,48576  14 18 19 20 21 23 24 25 26 34 35 36 40 24 24 
13 13q33.3  107627567        107853324 5,64E-06  0,000173307  225758  11 2,67353  8 9 16 27 28 29 30 31 39 43 48 13 1,48576  14 18 19 20 21 23 24 25 26 34 35 36 40 24 24 
13 13q33.3  108305634        108327674 3,43E-06  0,000171693  22041  11 2,69437  8 9 16 27 28 29 30 31 39 43 48 14 1,4786  14 18 19 20 21 23 24 25 26 33 34 35 36 40 25 23 
13 13q33.3  108327674        108695612 3,43E-06  0,000171693  367939  11 2,69437  8 9 16 27 28 29 30 31 39 43 48 13 1,48576  14 18 19 20 21 23 24 25 26 34 35 36 40 24 24 
13       13q33.3  - 13q34  108695612        110583312 3,43E-06  0,000171693           1887701  11 2,72983  8 9 16 27 28 29 30 31 39 43 48 13 1,48576  14 18 19 20 21 23 24 25 26 34 35 36 40 24 24 
13 13q34  110583312        111044610 1,51E-05  0,000294498  461299  12 2,69485  2 8 9 16 27 28 29 30 31 39 43 48 13 1,48576  14 18 19 20 21 23 24 25 26 34 35 36 40 25 23 
13 13q34  111044610        112522086 3,18E-05  0,000553553           1477477  13 2,66566  2 7 8 9 16 27 28 29 30 31 39 43 48 13 1,48576  14 18 19 20 21 23 24 25 26 34 35 36 40 26 22 
13 13q34  112522086        112668506 6,75E-05  0,000971133  146421  13 2,66566  2 7 8 9 16 27 28 29 30 31 39 43 48 13 1,51127  14 18 19 20 21 23 24 25 26 34 35 36 40 26 22 
13 13q34  112668506        112718722 6,75E-05  0,000971133  50217  13 2,66566  2 7 8 9 16 27 28 29 30 31 39 43 48 13 1,52668  14 18 19 20 21 23 24 25 26 34 35 36 40 26 22 
13 13q34  112718722        113124872 6,75E-05  0,000971133  406151  13 2,66566  2 7 8 9 16 27 28 29 30 31 39 43 48 13 1,52668  14 18 19 20 21 23 24 25 26 34 35 36 40 26 22 
14 14q11.2  19244855            19280237  2,45E-05  0,000443684  35383  1 2,33596  48 41 1,06188  1 2 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 20 21 22 23 24 25 26 27 28 29 31 32 33 34 35 42 6 
14 14q11.2  19280237            19490547  2,45E-05  0,000443684  210311  1 2,33596  48 41 1,04349  1 2 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 20 21 22 23 24 25 26 27 28 29 31 32 33 34 35 42 6 
14 14q11.2  22287328            22518386  1,14E-05  0,000248006  231059  1 2,389  16 20 1,45589  8 9 10 11 12 14 18 20 21 22 23 27 28 29 33 34 35 36 40 43 21 27 
14 14q11.2  22518386            22623353  1,29E-05  0,000262536  104968  1 2,389  16 20 1,54472  8 9 10 11 12 14 18 20 21 22 23 27 28 29 33 34 35 36 40 43 21 27 
14 14q11.2  22623353            22859317  1,29E-05  0,000262536  235965  1 2,389  16 20 1,54472  8 9 10 11 12 14 18 20 21 22 23 27 28 29 33 34 35 36 40 43 21 27 
14 14q11.2  22859317            23130166  1,29E-05  0,000262536  270850  1 2,389  16 20 1,53172  8 9 10 11 12 14 18 20 21 22 23 27 28 29 33 34 35 36 40 43 21 27 
14       14q11.2  - 14q12  23130166            23882816  1,29E-05  0,000262536  752651  1 2,389  16 21 1,532  8 9 10 11 12 14 18 20 21 22 23 27 28 29 32 33 34 35 36 40 43 22 26 
14 14q12  23882816            24525144  1,29E-05  0,000262536  642329  1 2,389  16 22 1,53404  8 9 10 11 12 14 18 20 21 22 23 27 28 29 31 32 33 34 35 36 40 43 23 25 
14 14q12  24525144            24561043  1,29E-05  0,000262536  35900  1 2,389  16 22 1,53404  8 9 10 11 12 14 18 20 21 22 23 27 28 29 31 32 33 34 35 36 40 43 23 25 
14 14q12  24561043            29122844  1,29E-05  0,000262536           4561802  1 2,389  16 23 1,53369  8 9 10 11 12 14 18 20 21 22 23 27 28 29 31 32 33 34 35 36 40 43 48 24 24 
14 14q12  29122844            29231719  1,29E-05  0,000262536  108876  1 2,389  16 22 1,53404  8 9 10 11 12 14 18 20 21 22 23 27 28 29 31 32 33 34 35 36 40 43 23 25 
14 14q12  29231719            29434301  1,29E-05  0,000262536  202583  1 2,389  16 23 1,51057  8 9 10 11 12 14 18 20 21 22 23 27 28 29 31 32 33 34 35 36 40 42 43 24 24 
14       14q12 - 14q13.2  29434301            35463933  1,29E-05  0,000262536           6029633  1 2,389  16 22 1,53404  8 9 10 11 12 14 18 20 21 22 23 27 28 29 31 32 33 34 35 36 40 43 23 25 
14     14q13.2  - 14q21.1  35463933            38659696  1,29E-05  0,000262536           3195764  1 2,389  16 23 1,53613  8 9 10 11 12 14 18 20 21 22 23 27 28 29 31 32 33 34 35 36 40 43 48 24 24 
14 14q21.1  38866201            39360684  1,37E-05  0,000272863  494484  1 2,389  16 23 1,5364  8 9 10 11 12 14 18 20 21 22 23 27 28 29 31 32 33 34 35 36 40 43 48 24 24 
14 14q21.1  39360684            39737953  1,37E-05  0,000272863  377270  1 2,389  16 23 1,52186  8 9 10 11 12 14 18 20 21 22 23 27 28 29 31 32 33 34 35 36 40 43 48 24 24 
14 14q32.33  104073951        104214391 2,85E-05  0,0005135  140441  8 2,85352  15 16 17 19 24 25 44 46 20 1,39012  1 2 4 5 6 7 8 10 12 22 26 27 28 29 32 35 36 40 42 43 28 20 
14 14q32.33  104214391        104312739 1,74E-05  0,000325316  98349  11 2,87255  12 13 15 16 17 19 24 25 26 44 46 17 1,41362  1 2 4 5 6 7 8 10 22 27 28 32 35 36 40 42 43 28 20 
14 14q32.33  105104539        105136219 1,37E-05  0,000272863  31681  19 3,07584  9 10 12 13 15 16 17 19 22 24 25 26 33 42 44 45 46 47 48 11 1,32473  1 2 4 5 6 7 27 28 31 32 36 30 18 
14 14q32.33  105136219        105304360 5,05E-06  0,000173307  168142  19 3,10195  9 10 12 13 15 16 17 19 22 24 25 26 33 42 44 45 46 47 48 11 1,26034  1 2 4 5 6 7 27 28 31 32 36 30 18 
14 14q32.33  105304360        105338567 5,05E-06  0,000173307  34208  17 2,99056  9 10 12 13 15 16 17 19 22 24 25 26 33 42 45 47 48 11 1,26034  1 2 4 5 6 7 27 28 31 32 36 28 20 
16 16p13.3  558720  675775  2,02E-05  0,00037379 117056  21 2,67665  9 11 12 13 14 15 16 17 18 20 23 24 25 26 32 34 36 43 44 45 46 5 1,12372  2 4 5 6 7 26 22 
16 16p13.3  675775  681066  4,10E-05  0,000696355  5292  20 2,6668  9 11 12 13 14 15 16 17 18 20 23 24 26 32 34 36 43 44 45 46 5 1,12372  2 4 5 6 7 25 23 
19 19p13.11  19715082            19738293  1,55E-05  0,000294498  23212  10 2,60867  8 9 28 29 32 37 40 42 44 48 7 1,56803  19 20 21 23 31 35 46 17 31 
19      19p13.11  - 19p12  19738293            19802995  1,55E-05  0,000294498  64703  8 2,62547  8 9 28 29 32 37 42 48 8 1,58308  19 20 21 23 31 35 44 46 16 32 
19 19p12  19802995            19860022  1,55E-05  0,000294498  57028  7 2,60999  8 9 28 29 37 42 48 8 1,58308  19 20 21 23 31 35 44 46 15 33 
19 19p12  19860022            19983604  1,55E-05  0,000294498  123583  8 2,5958  8 9 28 29 37 42 43 48 8 1,58308  19 20 21 23 31 35 44 46 16 32 
19 19p12  20127978            21344074  3,41E-06  0,000171693           1216097  7 2,54229  8 9 28 29 37 43 48 11 1,54066  19 20 21 22 23 31 34 35 42 44 46 18 30 
19 19p12  21344074            22175129  3,41E-06  0,000171693  831056  7 2,54229  8 9 28 29 37 43 48 12 1,52879  19 20 21 22 23 31 34 35 36 42 44 46 19 29 
19 19p12  22175129            23070339  3,41E-06  0,000171693  895211  6 2,54992  8 9 28 29 37 48 13 1,47833  19 20 21 22 23 31 34 35 36 42 43 44 46 19 29 
19 19p12  23070339            23681699  3,41E-06  0,000171693  611361  6 2,54992  8 9 28 29 37 48 12 1,48501  19 20 21 22 23 31 34 35 42 43 44 46 18 30 
19 19p12  23681699            23711544  3,41E-06  0,000171693  29846  6 2,54992  8 9 28 29 37 48 11 1,4821  19 20 21 22 23 31 35 42 43 44 46 17 31 
19         19p12 - 19p11  23711544            28338813  3,41E-06  0,000171693           4627270  6 2,54992  8 9 28 29 37 48 11 1,4821  19 20 21 22 23 31 35 42 43 44 46 17 31 
19         19p11 - 19q12  28338813            32754721  4,04E-06  0,000173307           4415909  9 2,56661  8 9 21 22 23 29 35 37 48 7 1,51687  19 20 31 42 43 44 46 16 32 
19 19q12  32754721            33031788  4,04E-06  0,000173307  277068  9 2,56661  8 9 21 22 23 29 35 37 48 7 1,62931  19 20 31 42 43 44 46 16 32 
19   19q13.11  - 19q13.12             40231679            40857477  7,47E-06  0,000190706  625799  13 2,63357  8 9 21 22 23 29 35 37 40 43 45 46 48 4 1,53116  13 15 19 20 17 31 
19 19q13.12  40979680            41016382  5,99E-05  0,000878529  36703  15 2,63372  8 9 21 22 23 24 25 29 35 37 40 43 45 46 48 5 1,28313  13 15 19 20 31 20 28 
19 19q13.12  41016382            41115596  5,72E-06  0,000173307  99215  13 2,63357  8 9 21 22 23 29 35 37 40 43 45 46 48 5 1,28313  13 15 19 20 31 18 30 
19 19q13.12  41115596            41264783  5,72E-06  0,000173307  149188  14 2,62128  8 9 21 22 23 29 32 35 37 40 43 45 46 48 5 1,28313  13 15 19 20 31 19 29 
19 19q13.12  41264783            41472929  5,72E-06  0,000173307  208147  14 2,62128  8 9 21 22 23 29 32 35 37 40 43 45 46 48 4 1,56224  13 15 19 20 18 30 
19 19q13.12  41472929            42993156  5,72E-06  0,000173307           1520228  11 2,61995  8 9 21 22 23 29 32 35 37 40 43 4 1,56224  13 15 19 20 15 33 
19   19q13.12  - 19q13.13             42993156            43107740  5,72E-06  0,000173307  114585  12 2,62385  8 9 21 22 23 29 32 35 37 40 43 48 4 1,56224  13 15 19 20 16 32 
19    19q13.13  - 19q13.2  43107740            44707934  5,72E-06  0,000173307           1600195  13 2,61275  8 9 21 22 23 29 32 35 37 40 43 45 48 4 1,56224  13 15 19 20 17 31 
19 19q13.2  44707934            44977336  5,72E-06  0,000173307  269403  12 2,62197  8 9 21 22 23 29 32 35 37 40 45 48 5 1,58576  13 15 19 20 43 17 31 
19 19q13.2  44977336            47550448  5,72E-06  0,000173307           2573113  13 2,62016  8 9 21 22 23 29 32 35 37 40 43 45 48 4 1,56224  13 15 19 20 17 31 
19    19q13.2  - 19q13.31  47779163            47911291  5,78E-06  0,000173874  132129  13 2,62147  8 9 21 22 23 29 32 35 37 40 43 45 48 4 1,56224  13 15 19 20 17 31 
19 19q13.31  48425188            49215048  5,47E-06  0,000173307  789861  13 2,62147  8 9 21 22 23 29 32 35 37 40 43 45 48 4 1,56224  13 15 19 20 17 31 
19 19q13.31  49215048            49309423  5,47E-06  0,000173307  94376  12 2,6177  8 9 21 22 23 29 32 35 37 40 43 45 4 1,56224  13 15 19 20 16 32 
19 19q13.31  49309423            49692017  5,47E-06  0,000173307  382595  11 2,63026  8 9 21 22 23 29 32 35 37 40 43 4 1,56224  13 15 19 20 15 33 
19 19q13.31  49692017            49730102  5,47E-06  0,000173307  38086  12 2,63798  8 9 21 22 23 29 32 35 37 40 43 48 4 1,56224  13 15 19 20 16 32 
19   19q13.31  - 19q13.32             49730102            51175833  5,47E-06  0,000173307           1445732  13 2,63425  8 9 21 22 23 29 32 35 37 40 43 45 48 4 1,56224  13 15 19 20 17 31 
19 19q13.32  51175833            53447663  5,47E-06  0,000173307           2271831  14 2,63914  8 9 21 22 23 29 32 35 37 39 40 43 45 48 4 1,56224  13 15 19 20 18 30 
19 19q13.32  53447663            53625403  5,47E-06  0,000173307  177741  15 2,68176  8 9 21 22 23 28 29 32 35 37 39 40 43 45 48 4 1,56224  13 15 19 20 19 29 
19   19q13.32  - 19q13.33             53625403            56153019  5,47E-06  0,000173307           2527617  14 2,63914  8 9 21 22 23 29 32 35 37 39 40 43 45 48 4 1,56224  13 15 19 20 18 30 
19 19q13.33  56153019            56728844  5,47E-06  0,000173307  575826  13 2,64297  8 9 21 22 23 29 32 35 37 39 40 43 48 4 1,56224  13 15 19 20 17 31 
19   19q13.33  - 19q13.41             56728844            59073302  5,47E-06  0,000173307           2344459  12 2,6363  8 9 21 22 23 29 32 35 37 39 40 43 4 1,56224  13 15 19 20 16 32 
19   19q13.41  - 19q13.42             59073302            59926385  5,47E-06  0,000173307  853084  13 2,64503  8 9 21 22 23 29 32 35 37 39 40 43 48 4 1,56224  13 15 19 20 17 31 
19 19q13.42  59926385            60223566  5,47E-06  0,000173307  297182  13 2,64503  8 9 21 22 23 29 32 35 37 39 40 43 48 5 1,50805  13 15 19 20 33 18 30 
19 19q13.42  60223566            60851243  5,47E-06  0,000173307  627678  13 2,64503  8 9 21 22 23 29 32 35 37 39 40 43 48 4 1,56224  13 15 19 20 17 31 
19   19q13.42  - 19q13.43             60851243            63745505  5,47E-06  0,000173307           2894263  13 2,61892  8 9 21 22 23 29 32 35 37 39 40 43 48 4 1,56224  13 15 19 20 17 31 
20 20p13  378409  599153  2,39E-05  0,000438182  220745  24 3,06386  9 10 11 12 14 15 16 17 18 19 20 24 26 28 29 31 32 33 34 36 43 44 45 48 3 1,16296  6 7 30 27 21 
21     21p11.2  - 21q11.2  9896656            13357496  4,70E-05  0,000761937           3460841  4 2,53574  8 9 16 29 14 1,56484  3 13 19 20 27 31 32 33 35 36 38 40 44 46 18 30 
21 21q22.3  44395713            44407647  4,17E-05  0,00070451 11935  8 2,49007  8 9 14 23 29 40 43 48 7 1,58853  19 27 32 33 36 44 46 15 33 













HUGO Gene Symbol Nominal p-value FDR Patient specific in % of comparisons Gene description RefSeq Affymetrix TC ID GO_biological_process 
CDH3 2,84E-10 8,20E-06 71 NM_001793  // CDH3 // cadherin 3, type 1, P-cadherin  (placental)  // 16q22.1 // 10 NM_001793 7996819 NM_001793  // GO:0007155  // cell adhesion // traceable author statement   /// NM_0 
KIT 1,29E-08 4,65E-05 75 NM_000222  // KIT // v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolo NM_000222 8095110 NM_000222  // GO:0002318  // myeloid progenitor  cell differentiation // inferred f 
CYGB 5,29E-07 6,88E-04 71 NM_134268  // CYGB // cytoglobin // 17q25.3 // 114757 /// ENST00000293230 // CYGB NM_134268 8018754 NM_134268  // GO:0006810  // transport // inferred from electronic annotation   /// 
NNMT 1,10E-06 1,01E-03 75 NM_006169  // NNMT // nicotinamide  N-methyltransferase // 11q23.1 // 4837 /// ENS NM_006169 7943998 --- 
NAA11 1,21E-06 1,01E-03 82 NM_032693  // NAA11 // N(alpha)-acetyltransferase 11, NatA catalytic subunit // 4 NM_032693 8101253 NM_032693  // GO:0008152  // metabolic process // inferred from electronic annotat 
BAGE2 2,49E-06 1,44E-03 75 NM_182482  // BAGE2 // B melanoma  antigen family, member 2 // 21p // 85319 /// NM NM_182482 8069487 --- 
TPTE 3,42E-06 1,73E-03 75 NM_199261  // TPTE // transmembrane phosphatase  with tensin homology // 21p11 // NM_199261 8069472 NM_199261  // GO:0006470  // protein amino acid dephosphorylation // inferred from 
 
1,22E-05 3,58E-03 71 --- --- 8045525 --- 
GNAL 1,46E-05 3,97E-03 71 NM_182978  // GNAL // guanine nucleotide binding protein (G protein), alpha activ NM_182978 8020164 NM_182978  // GO:0007165  // signal transduction  // inferred from electronic annot 
TUBA8 1,93E-05 4,56E-03 79 NM_018943  // TUBA8 // tubulin, alpha 8 // 22q11.1 // 51807 /// ENST00000330423 / NM_018943 8071147 NM_018943  // GO:0007018  // microtubule-based movement  // inferred from electroni 
MAGEC2 2,12E-05 4,75E-03 75 NM_016249  // MAGEC2 // melanoma  antigen family C, 2 // Xq27 // 51438 /// ENST000 NM_016249 8175562 --- 
TF 2,18E-05 4,80E-03 79 NM_001063  // TF // transferrin  // 3q22.1 // 7018 /// ENST00000264998 // TF // tr NM_001063 8082797 NM_001063  // GO:0006811  // ion transport // inferred from electronic annotation 
RNASE1 2,34E-05 5,04E-03 71 NM_198232  // RNASE1 // ribonuclease, RNase A family, 1 (pancreatic)  // 14q11.2 / NM_198232 7977615 --- 
HORMAD1 2,58E-05 5,11E-03 82 NM_032132  // HORMAD1  // HORMA domain containing  1 // 1q21.3 // 84072 /// ENST000 NM_032132 7919787 NM_032132  // GO:0007067  // mitosis // inferred from electronic annotation   /// N 
CFI 2,82E-05 5,11E-03 79 NM_000204  // CFI // complement  factor I // 4q25 // 3426 /// ENST00000394634 // C NM_000204 8102328 NM_000204  // GO:0006508  // proteolysis  // inferred from electronic annotation   / 
MAGEB2 3,47E-05 5,59E-03 71 NM_002364  // MAGEB2 // melanoma  antigen family B, 2 // Xp21.3 // 4113 /// ENST00 NM_002364 8166611 --- 
MAGEA4 3,60E-05 5,69E-03 75 NM_001011548 // MAGEA4 // melanoma  antigen family A, 4 // Xq28 // 4103 /// NM_00 NM_001011548 8170531 NM_001011548 // GO:0008150  // biological_process // no biological data available 
RGS5 5,74E-05 7,47E-03 71 NM_003617  // RGS5 // regulator of G-protein signaling 5 // 1q23.1 // 8490 /// EN NM_003617 7921916 NM_003617  // GO:0008277  // regulation of G-protein coupled receptor protein sign 
ITGA4 1,11E-04 1,06E-02 75 NM_000885  // ITGA4 // integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 NM_000885 8046695 NM_000885  // GO:0001974  // blood vessel remodeling  // inferred from electronic a 
TM4SF1 1,13E-04 1,07E-02 75 NM_014220  // TM4SF1 // transmembrane 4 L six family member 1 // 3q21-q25 // 4071 NM_014220 8091411 NM_014220  // GO:0008150  // biological_process // no biological data available  / 
TDO2 1,24E-04 1,13E-02 75 NM_005651  // TDO2 // tryptophan  2,3-dioxygenase // 4q31-q32 // 6999 /// ENST0000 NM_005651 8097991 NM_005651  // GO:0019441  // tryptophan  catabolic process to kynurenine  // inferre 
SERPINA3 1,45E-04 1,23E-02 82 NM_001085  // SERPINA3 // serpin peptidase inhibitor, clade A (alpha-1 antiprotei NM_001085 7976496 NM_001085  // GO:0006953  // acute-phase  response // inferred from electronic anno 
ARHGEF6 1,88E-04 1,46E-02 71 NM_004840  // ARHGEF6 // Rac/Cdc42  guanine nucleotide  exchange factor (GEF) 6 // NM_004840 8175393 NM_004840  // GO:0006915  // apoptosis // not recorded  /// NM_004840  // GO:000691 
DKK3 2,64E-04 1,81E-02 71 NM_015881  // DKK3 // dickkopf homolog 3 (Xenopus laevis) // 11p15.2 // 27122 /// NM_015881 7946661 NM_015881  // GO:0007275  // multicellular  organismal  development  // inferred from 
APCDD1 2,82E-04 1,85E-02 75 NM_153000  // APCDD1 // adenomatosis polyposis coli down-regulated 1 // 18p11.22 NM_153000 8020141 --- 
LOC100133469 3,14E-04 1,98E-02 71 NR_027457  // LOC100133469 // hypothetical  LOC100133469 // --- // 100133469 NR_027457 7977447 --- 
DSCR8 3,63E-04 2,16E-02 75 NR_026839  // DSCR8 // Down syndrome critical region gene 8 // 21q22.2 // 84677 / NR_026839 8068570 NR_026839  // GO:0008150  // biological_process // no biological data available  / 
SLAMF7 4,81E-04 2,55E-02 75 NM_021181  // SLAMF7 // SLAM family member 7 // 1q23.1-q24.1  // 57823 /// ENST000 NM_021181 7906613 NM_021181  // GO:0007155  // cell adhesion // non-traceable author statement   /// 
VAMP8 8,46E-04 3,49E-02 75 NM_003761  // VAMP8 // vesicle-associated membrane  protein 8 (endobrevin)  // 2p12 NM_003761 8043197 NM_003761  // GO:0006461  // protein complex assembly // inferred from electronic 
MGP 8,57E-04 3,51E-02 86 NM_000900  // MGP // matrix Gla protein // 12p13.1-p12.3 // 4256 /// ENST00000228 NM_000900 7961514 NM_000900  // GO:0001502  // cartilage condensation // traceable author statement 
CD200 8,74E-04 3,55E-02 71 NM_001004196 // CD200 // CD200 molecule // 3q12-q13 // 4345 /// NM_005944  // CD2 NM_001004196 8081657 --- 
CD302 8,76E-04 3,55E-02 75 NM_014880  // CD302 // CD302 molecule // 2q24.2 // 9936 /// ENST00000259053 // CD NM_014880 8056102 --- 
FLRT3 1,10E-03 4,05E-02 75 NM_198391  // FLRT3 // fibronectin  leucine rich transmembrane protein 3 // 20p11 NM_198391 8065071 NM_198391  // GO:0007155  // cell adhesion // inferred from electronic annotation 
C1S 1,17E-03 4,16E-02 75 NM_201442  // C1S // complement  component  1, s subcomponent // 12p13 // 716 /// N NM_201442 7953603 NM_201442  // GO:0006508  // proteolysis  // inferred from electronic annotation   / 
MME 1,26E-03 4,33E-02 79 NM_007288  // MME // membrane  metallo-endopeptidase // 3q25.1-q25.2  // 4311 /// N NM_007288 8083494 NM_007288  // GO:0006508  // proteolysis  // inferred from electronic annotation   / 
CYorf15B 1,26E-03 4,33E-02 71 NM_032576  // CYorf15B // chromosome  Y open reading frame 15B // Yq11.222 // 8466 NM_032576 8176709 --- 
SLITRK6 1,40E-03 4,63E-02 75 NM_032229  // SLITRK6 // SLIT and NTRK-like family, member 6 // 13q31.1 // 84189 NM_032229 7972239 NM_032229  // GO:0007409  // axonogenesis // inferred from electronic annotation 
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